HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response

High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metasta...

Full description

Saved in:
Bibliographic Details
Published inPharmacological research Vol. 190; p. 106732
Main Authors Hashemi, Mehrdad, Rashidi, Mohsen, Hushmandi, Kiavash, ten Hagen, Timo L.M., Salimimoghadam, Shokooh, Taheriazam, Afshin, Entezari, Maliheh, Falahati, Mojtaba
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.04.2023
Elsevier
Subjects
Cancer
Cell Line, Tumor
CircRNAs
HMGA2
HMGA2 Protein - metabolism
Humans
LncRNA
MicroRNAs - genetics
MicroRNAs - metabolism
MiRNA
Neoplasms - drug therapy
Neoplasms - genetics
RNA, Circular - genetics
RNA, Long Noncoding - metabolism
RNA, Untranslated - genetics
EIF4A2
LSCC
RKIP
SERPINE1
TGF-βR1
LncRNA
NR3C1
BZW1
CircRNA
SOX2
HOXA9
PI3K
SOX4
PDGFRA
CPT1A
MDR-1
POSTN
MiRNA
AI
MITF
Snail
DCTD
EGF-L7
PDAC
HNSCC
RBP1
TXNIP
CircRNAs
ERK
ceRNA
ABCB1
YAP
Chk1
HIF1A
IKKε
HBXIP
GSK-3β
PD-L1
ATG5
SMAD2
OSCC
KLHL21
HMGA2
NETO2
PAICS
HNRNPK
SP1
ZEB
MDM2
NF1
TCF3
ATR
Cancer
TAM
FEN1
HNF4G
PTEN
LAMC2
BRCA1
ALDH1
LTBP-1
DNMT3B
mTOR
OLR1
P-gp
MMP2
HCC
TET1
FOXL2
MAPK
ESCC
LATS1
PCL
MET
PTC
Bcl-2
VEGFR2
NF-κB1
ROCK1
THBS2
CBP
ER-α36
BCLAF1
GBM
MTA1
U2AF2
TP53INP1
E2F1
Foxi1
PP4R1
AP1
Tgfbr3
STAT3
NcRNA
HN1
TME
FAK
PEG
PLGA
APC
KRT17
PEI
eIF5A2
Online AccessGet full text

Cover

Abstract High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metastasis, and therapy resistance. HMGA2 targets critical signaling pathways such as Wnt/β-catenin and mTOR in cancer cells. Therefore, suppression of HMGA2 function notably decreases cancer progression and improves outcome in patients. As HMGA2 is mainly oncogenic, targeting expression by non-coding RNAs (ncRNAs) is crucial to take into consideration since it affects HMGA2 function. MicroRNAs (miRNAs) belong to ncRNAs and are master regulators of vital cell processes, which affect all aspects of cancer hallmarks. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs), other members of ncRNAs, are upstream mediators of miRNAs. The current review intends to discuss the importance of the miRNA/HMGA2 axis in modulation of various types of cancer, and mentions lncRNAs and circRNAs, which regulate this axis as upstream mediators. Finally, we discuss the effect of miRNAs and HMGA2 interactions on the response of cancer cells to therapy. Regarding the critical role of HMGA2 in regulation of critical signaling pathways in cancer cells, and considering the confirmed interaction between HMGA2 and one of the master regulators of cancer, miRNAs, targeting miRNA/HMGA2 axis in cancer therapy is promising and this could be the subject of future clinical trial experiments. [Display omitted]
AbstractList High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metastasis, and therapy resistance. HMGA2 targets critical signaling pathways such as Wnt/β-catenin and mTOR in cancer cells. Therefore, suppression of HMGA2 function notably decreases cancer progression and improves outcome in patients. As HMGA2 is mainly oncogenic, targeting expression by non-coding RNAs (ncRNAs) is crucial to take into consideration since it affects HMGA2 function. MicroRNAs (miRNAs) belong to ncRNAs and are master regulators of vital cell processes, which affect all aspects of cancer hallmarks. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs), other members of ncRNAs, are upstream mediators of miRNAs. The current review intends to discuss the importance of the miRNA/HMGA2 axis in modulation of various types of cancer, and mentions lncRNAs and circRNAs, which regulate this axis as upstream mediators. Finally, we discuss the effect of miRNAs and HMGA2 interactions on the response of cancer cells to therapy. Regarding the critical role of HMGA2 in regulation of critical signaling pathways in cancer cells, and considering the confirmed interaction between HMGA2 and one of the master regulators of cancer, miRNAs, targeting miRNA/HMGA2 axis in cancer therapy is promising and this could be the subject of future clinical trial experiments.High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metastasis, and therapy resistance. HMGA2 targets critical signaling pathways such as Wnt/β-catenin and mTOR in cancer cells. Therefore, suppression of HMGA2 function notably decreases cancer progression and improves outcome in patients. As HMGA2 is mainly oncogenic, targeting expression by non-coding RNAs (ncRNAs) is crucial to take into consideration since it affects HMGA2 function. MicroRNAs (miRNAs) belong to ncRNAs and are master regulators of vital cell processes, which affect all aspects of cancer hallmarks. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs), other members of ncRNAs, are upstream mediators of miRNAs. The current review intends to discuss the importance of the miRNA/HMGA2 axis in modulation of various types of cancer, and mentions lncRNAs and circRNAs, which regulate this axis as upstream mediators. Finally, we discuss the effect of miRNAs and HMGA2 interactions on the response of cancer cells to therapy. Regarding the critical role of HMGA2 in regulation of critical signaling pathways in cancer cells, and considering the confirmed interaction between HMGA2 and one of the master regulators of cancer, miRNAs, targeting miRNA/HMGA2 axis in cancer therapy is promising and this could be the subject of future clinical trial experiments.
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metastasis, and therapy resistance. HMGA2 targets critical signaling pathways such as Wnt/β-catenin and mTOR in cancer cells. Therefore, suppression of HMGA2 function notably decreases cancer progression and improves outcome in patients. As HMGA2 is mainly oncogenic, targeting expression by non-coding RNAs (ncRNAs) is crucial to take into consideration since it affects HMGA2 function. MicroRNAs (miRNAs) belong to ncRNAs and are master regulators of vital cell processes, which affect all aspects of cancer hallmarks. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs), other members of ncRNAs, are upstream mediators of miRNAs. The current review intends to discuss the importance of the miRNA/HMGA2 axis in modulation of various types of cancer, and mentions lncRNAs and circRNAs, which regulate this axis as upstream mediators. Finally, we discuss the effect of miRNAs and HMGA2 interactions on the response of cancer cells to therapy. Regarding the critical role of HMGA2 in regulation of critical signaling pathways in cancer cells, and considering the confirmed interaction between HMGA2 and one of the master regulators of cancer, miRNAs, targeting miRNA/HMGA2 axis in cancer therapy is promising and this could be the subject of future clinical trial experiments.
High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during carcinogenesis, and this protein is an upstream mediator of cancer hallmarks including evasion of apoptosis, proliferation, invasion, metastasis, and therapy resistance. HMGA2 targets critical signaling pathways such as Wnt/β-catenin and mTOR in cancer cells. Therefore, suppression of HMGA2 function notably decreases cancer progression and improves outcome in patients. As HMGA2 is mainly oncogenic, targeting expression by non-coding RNAs (ncRNAs) is crucial to take into consideration since it affects HMGA2 function. MicroRNAs (miRNAs) belong to ncRNAs and are master regulators of vital cell processes, which affect all aspects of cancer hallmarks. Long ncRNAs (lncRNAs) and circular RNAs (circRNAs), other members of ncRNAs, are upstream mediators of miRNAs. The current review intends to discuss the importance of the miRNA/HMGA2 axis in modulation of various types of cancer, and mentions lncRNAs and circRNAs, which regulate this axis as upstream mediators. Finally, we discuss the effect of miRNAs and HMGA2 interactions on the response of cancer cells to therapy. Regarding the critical role of HMGA2 in regulation of critical signaling pathways in cancer cells, and considering the confirmed interaction between HMGA2 and one of the master regulators of cancer, miRNAs, targeting miRNA/HMGA2 axis in cancer therapy is promising and this could be the subject of future clinical trial experiments. [Display omitted]
ArticleNumber 106732
Author Salimimoghadam, Shokooh
Rashidi, Mohsen
Hashemi, Mehrdad
Entezari, Maliheh
Taheriazam, Afshin
Falahati, Mojtaba
Hushmandi, Kiavash
ten Hagen, Timo L.M.
Author_xml – sequence: 1
  givenname: Mehrdad
  surname: Hashemi
  fullname: Hashemi, Mehrdad
  email: mhashemi@iautmu.ac.ir
  organization: Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
– sequence: 2
  givenname: Mohsen
  surname: Rashidi
  fullname: Rashidi, Mohsen
  email: dr.mohsenrashidi@yahoo.com
  organization: Department Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari 4815733971, Iran
– sequence: 3
  givenname: Kiavash
  surname: Hushmandi
  fullname: Hushmandi, Kiavash
  email: houshmandi.kia7@ut.ac.ir
  organization: Department of Food Hygiene and Quality Control, Division of Epidemiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
– sequence: 4
  givenname: Timo L.M.
  surname: ten Hagen
  fullname: ten Hagen, Timo L.M.
  email: t.l.m.tenhagen@erasmusmc.nl
  organization: Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands
– sequence: 5
  givenname: Shokooh
  surname: Salimimoghadam
  fullname: Salimimoghadam, Shokooh
  email: Shokoohmoghadam@yahoo.com
  organization: Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran
– sequence: 6
  givenname: Afshin
  surname: Taheriazam
  fullname: Taheriazam, Afshin
  email: a.taheriazam@iautmu.ac.ir
  organization: Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
– sequence: 7
  givenname: Maliheh
  surname: Entezari
  fullname: Entezari, Maliheh
  email: mentezari@iautmu.ac.ir
  organization: Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
– sequence: 8
  givenname: Mojtaba
  surname: Falahati
  fullname: Falahati, Mojtaba
  email: m.falahati@erasmusmc.nl
  organization: Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36931542$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1vEzEUtFAr-gF_gAPaI5cN_t414hJV9EMqRUL0bNnet4nDxl7sDVL-fZ1uyoFDT7bmzcx7mrlAJyEGQOgDwQuCify8WYzrlBcUU1YA2TD6Bp0TrGRNSCtPDn_OailJe4Yuct5gjBUn-C06Y1IxIjg9R4-332-WtEqw2g1m8jFUdl9t_c-HZa58qJwJDtKXatn34CYfVkekWpth2Jr0O1cmdNW0hmTGfbHJYwwZ3qHT3gwZ3h_fS_R4_e3X1W19_-Pm7mp5Xzsu5VRzAhgMYR3uaSMa3FkQWDhs2zKnltrOKcUxOAmtpK4VvFNWNq4RnTAMJLtEd7NvF81Gj8mXk_Y6Gq-fgZhW2qTJuwG0EoQK1tsGpOLGENWXvJyiTPXSWa6K16fZa0zxzw7ypLc-OxgGEyDusqaNogrzlh7WfjxSd3YL3b_FL7EWQjsTXIo5J-i189NzvFMyftAE60ODutxcGtSHBvXcYJHS_6Qv7q-Kvs4iKGH_9ZB0dh5KUZ1PpbeShn9N_gQCtrKS
CitedBy_id crossref_primary_10_1016_j_biopha_2024_117465
crossref_primary_10_1016_j_phrs_2024_107299
crossref_primary_10_1007_s12672_024_01202_x
crossref_primary_10_3389_fonc_2024_1320887
crossref_primary_10_2147_OTT_S475132
crossref_primary_10_1186_s13148_025_01852_w
crossref_primary_10_1016_j_talanta_2025_127788
crossref_primary_10_1007_s13258_023_01461_y
crossref_primary_10_1007_s10142_024_01431_x
crossref_primary_10_1016_j_heliyon_2024_e27268
crossref_primary_10_1186_s13018_025_05537_1
crossref_primary_10_1038_s41419_024_06592_y
crossref_primary_10_1186_s13062_024_00490_1
crossref_primary_10_2217_epi_2023_0053
crossref_primary_10_1007_s11033_024_09316_9
crossref_primary_10_1038_s41598_024_75491_1
crossref_primary_10_1016_j_molmed_2024_07_004
crossref_primary_10_1016_j_prp_2023_154959
crossref_primary_10_1515_oncologie_2023_0530
crossref_primary_10_1016_j_bcp_2024_116218
crossref_primary_10_1186_s13046_025_03279_w
Cites_doi 10.1002/jcb.28024
10.3390/cancers13010027
10.1186/s12885-021-09020-y
10.1002/cam4.1491
10.1007/s00280-019-03866-7
10.1002/1878-0261.13192
10.1016/j.ijbiomac.2023.123377
10.1016/j.phrs.2022.106535
10.3892/ijo.2021.5178
10.1016/j.phrs.2022.106418
10.1038/s12276-020-0380-6
10.1038/nature12785
10.1038/s41420-022-00938-1
10.1007/s12038-016-9603-3
10.1111/nyas.14717
10.3727/096504019X15619783964700
10.1186/s11658-022-00344-6
10.23736/S0390-5616.19.04792-1
10.1016/j.cca.2019.07.004
10.1016/j.biopha.2016.04.034
10.1042/BSR20190421
10.1093/abbs/gmab058
10.1186/s12935-020-01322-8
10.2147/OTT.S209138
10.1016/j.biotechadv.2017.03.002
10.18632/oncotarget.13187
10.1016/j.yexcr.2022.113271
10.1080/21655979.2022.2033447
10.1186/s13045-020-00990-3
10.1073/pnas.1305172110
10.1016/j.bbagrm.2009.09.001
10.1016/j.ijbiomac.2017.07.053
10.1038/s41419-019-1513-5
10.1016/j.phrs.2022.106475
10.7150/thno.20041
10.1016/j.biopha.2019.109403
10.1002/mc.23168
10.1159/000518627
10.2147/CMAR.S230367
10.21873/anticanres.11527
10.18632/oncotarget.18671
10.1016/j.ejphar.2019.03.005
10.1016/j.matbio.2018.09.002
10.1016/S0079-6603(08)60360-8
10.1002/jcp.28745
10.2147/CMAR.S237752
10.1038/s41598-019-54289-6
10.1038/s12276-022-00837-6
10.1158/1078-0432.CCR-17-2967
10.2147/CMAR.S199289
10.1007/s13277-015-4625-2
10.18632/oncotarget.9744
10.18632/oncotarget.3288
10.1186/s11658-022-00348-2
10.1002/jbt.22921
10.1016/j.celrep.2014.01.014
10.1186/1475-2867-13-95
10.12659/MSM.898740
10.1128/MCB.00445-20
10.4314/tjpr.v20i7.3
10.3727/096504018X15202945197589
10.1002/gcc.20505
10.1177/1724600819874488
10.1016/j.yexcr.2020.112088
10.1158/1541-7786.MCR-07-0095
10.3892/ol.2021.12496
10.2147/OTT.S161996
10.1111/odi.14399
10.2147/OTT.S263090
10.1080/15384047.2015.1095405
10.2147/CMAR.S282625
10.1021/acsami.9b02756
10.1177/0963689720925059
10.18632/oncotarget.24133
10.1186/s12935-021-02088-3
10.1186/s12967-016-0777-0
10.1093/abbs/gmab041
10.18632/oncotarget.24080
10.1016/j.dld.2019.11.017
10.1200/JCO.2009.26.6213
10.1002/jcb.28411
10.2147/OTT.S218308
10.1002/jcb.29542
10.1002/iub.2452
10.3390/cancers6031769
10.1016/j.nano.2021.102494
10.1038/s41598-022-07468-x
10.1158/1538-7445.AM2020-2517
10.1016/j.bbrc.2018.08.155
10.1111/odi.12608
10.18632/aging.204193
10.3390/ijms21030869
10.1002/path.4994
10.1002/cam4.1534
10.1177/1073274820904694
10.18632/aging.102519
10.2147/OTT.S237069
10.1002/cam4.1353
10.3233/CBM-182315
10.1042/BSR20182101
10.1186/s12935-019-0875-1
10.1038/s41388-019-0986-0
10.1038/labinvest.2013.120
10.1016/j.biopha.2017.08.057
10.1016/j.canlet.2016.04.005
10.1002/emmm.201201320
10.1007/s10120-019-00976-2
10.3892/etm.2017.4253
10.2147/OTT.S283786
10.1016/0168-9525(94)90232-1
10.1038/s41419-021-03891-6
10.1186/s40659-018-0199-y
10.1038/srep13827
10.14715/cmb/2019.65.7.20
10.3892/or.2016.5255
10.1002/cam4.1809
10.1038/s41419-020-2726-3
10.1016/j.abb.2016.09.007
10.1007/s10549-015-3431-2
10.1186/s13148-020-0821-z
10.1002/ijc.23491
10.1159/000430172
10.1002/2211-5463.12716
10.1186/s12958-022-01011-3
10.1038/cddis.2017.134
10.1038/s41416-021-01588-3
10.1111/cns.12850
10.1007/s10620-020-06805-2
10.2147/CMAR.S274856
10.1002/ctm2.780
10.1016/j.reprotox.2021.12.011
10.1007/s10549-021-06433-y
10.1038/s41419-021-03753-1
10.1016/j.omtn.2019.11.008
10.7150/thno.38327
10.1111/cpr.12096
10.1039/C9NR09011H
10.1111/1759-7714.12476
10.1038/jid.2013.197
10.1111/eci.13563
10.1016/j.biopha.2019.108998
10.1002/jcp.26611
10.2147/OTT.S114303
10.5808/GI.2020.18.4.e36
10.1186/s13046-018-0686-6
10.1186/s12935-020-01706-w
10.1038/s41419-021-04123-7
10.1038/s41598-023-27415-8
10.7150/thno.65411
10.1016/j.cellsig.2021.110095
10.1007/s10528-021-10082-7
10.1002/jbt.22910
10.1007/s11060-018-2951-0
10.1016/j.cell.2006.05.052
10.3892/ijo.2014.2360
10.3390/cancers11101482
10.1111/his.13456
10.1007/s13277-015-3853-9
10.1016/j.biopha.2022.113609
10.1101/gad.1540407
10.18632/oncotarget.8288
10.1016/j.tranon.2020.100894
10.18632/oncotarget.683
10.1111/exd.14174
10.1177/1010428317719274
10.1158/1541-7786.MCR-19-0718
10.1042/BSR20190635
10.1186/s12964-022-01017-9
10.1016/j.prp.2021.153420
10.1016/j.cca.2019.08.031
10.7150/jca.34650
10.7150/jca.14440
10.3390/ijms18112317
10.1016/j.jconrel.2019.07.006
10.1186/s12967-015-0462-8
10.1007/s13577-019-00290-0
10.1007/s11356-018-1784-x
10.18632/oncotarget.15795
10.1007/s00018-018-2958-x
10.3390/cells11152332
10.1177/08839115221095152
10.3390/jcm8122115
10.1038/nrc2271
10.1038/onc.2014.314
10.1016/j.biopha.2017.11.113
10.7150/jca.62652
10.1074/jbc.M117.783738
10.18632/aging.103464
10.1158/1541-7786.c.6545664
10.1042/BSR20193788
10.3892/mmr.2021.12085
10.3390/ijms24031824
10.1007/s12672-019-00370-5
10.3892/ol.2022.13269
10.3390/cancers13205197
10.1111/jcmm.14884
10.1016/j.ccr.2006.04.024
10.3892/or.2021.8190
10.3892/or.2015.3882
10.1080/15384101.2019.1652035
10.3390/cancers14153818
10.1097/PAI.0000000000000637
10.1016/j.ijbiomac.2022.09.203
10.18632/aging.101843
10.1016/j.canlet.2016.04.020
10.3390/ijms21103610
10.18632/aging.102628
10.3892/mmr.2017.7000
10.1016/j.ejphar.2022.175212
10.18632/oncotarget.7989
10.1002/cncy.20095
10.1038/nrc3599
10.3389/fcell.2014.00005
10.18632/oncotarget.7168
10.3389/fonc.2019.01526
10.1016/j.omtn.2019.04.017
10.3390/ijms20102473
10.1002/jcb.29477
10.3390/cancers12051197
10.1016/S1995-7645(14)60040-7
10.1038/s41388-019-0952-x
10.1038/s41420-022-01283-z
10.1016/j.biopha.2021.111366
10.1038/s41419-018-1188-3
10.1016/j.omtn.2021.04.011
10.3892/ol.2013.1193
10.1002/jcla.24422
10.1016/0167-4781(90)90092-G
10.1007/s13277-014-2185-5
10.1016/j.brainres.2016.04.066
10.1002/mc.20235
10.1038/s41598-018-32159-x
10.1007/s13277-016-5210-z
10.1016/j.ejca.2008.02.039
10.1159/000481610
10.1093/carcin/bgac033
10.18632/oncotarget.23826
10.1080/15384047.2016.1235661
10.1038/s41417-021-00362-0
10.1080/15384101.2021.1924948
10.1242/bio.015008
10.1097/CAD.0000000000001284
10.2147/OTT.S184235
10.3390/pharmaceutics14081620
10.18632/oncotarget.15531
10.1186/s12935-020-01318-4
10.2147/OTT.S74397
10.1089/cbr.2019.3017
10.1158/1078-0432.CCR-16-2180
10.3892/ijmm.2020.4634
10.1186/1475-2867-3-1
10.3390/cancers12071852
10.1016/j.prp.2022.153913
10.3727/096504019X15761480623959
10.1016/j.clbc.2021.08.009
10.1002/jcla.23044
10.1016/j.ejso.2011.01.004
10.1038/onc.2015.217
10.1159/000452539
10.4238/gmr.15028173
10.3892/ol.2016.4162
10.1097/MPH.0b013e318197978d
10.1002/jcp.27915
10.1093/nar/gkaa232
10.1016/j.biopha.2022.113774
10.1016/j.canlet.2015.07.044
10.1111/j.1432-1033.1973.tb03026.x
10.20944/preprints202110.0289.v1
10.1080/21655979.2022.2044277
10.1186/s13046-021-01896-9
10.1016/j.biochi.2018.12.003
10.1007/s10571-017-0466-4
10.3727/096504020X15928179818438
10.1016/j.omtn.2018.09.007
10.1186/s11658-019-0168-7
10.1038/modpathol.2010.49
10.1007/s10735-020-09883-8
10.1016/j.jconrel.2022.07.027
10.1002/jbm.a.36840
10.2147/OTT.S280912
10.1186/s12943-022-01530-y
10.1016/j.drudis.2016.10.014
10.1097/CAD.0000000000000700
10.1038/s41586-019-1730-1
10.1093/jb/mvab011
10.1039/D1BM01124C
10.1038/s10038-020-0795-x
10.1186/s13046-021-02175-3
10.3390/cells11193065
10.2147/OTT.S210567
10.1080/1061186X.2017.1323220
10.1371/journal.pone.0185636
10.1016/j.bbrc.2015.05.068
10.1186/s12929-022-00824-z
10.3390/cells12040525
10.1186/1747-1028-1-17
10.1016/j.canlet.2019.03.032
ContentType Journal Article
Copyright 2023 The Authors
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Copyright_xml – notice: 2023 The Authors
– notice: Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1016/j.phrs.2023.106732
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1096-1186
ExternalDocumentID oai_doaj_org_article_951253fb7e694aa19f732c9239f6cb49
36931542
10_1016_j_phrs_2023_106732
S1043661823000889
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
0SF
0ZK
123
1B1
1RT
1~.
1~5
29O
3O-
4.4
457
4G.
53G
5RE
5VS
6I.
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HMT
HVGLF
HX~
HZ~
IHE
J1W
KOM
L7B
LG5
M33
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSP
SSZ
T5K
TEORI
UNMZH
WUQ
XPP
ZA5
ZU3
ZXP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFKBS
ID FETCH-LOGICAL-c466t-41e0ea13d0f27570dbe505c0b8c462b2bdc9940ec6e862c854d9b67c75d5a3e63
IEDL.DBID .~1
ISSN 1043-6618
1096-1186
IngestDate Wed Aug 27 01:09:06 EDT 2025
Fri Jul 11 08:11:59 EDT 2025
Wed Feb 19 02:24:14 EST 2025
Thu Apr 24 23:00:57 EDT 2025
Tue Jul 01 03:33:55 EDT 2025
Fri Feb 23 02:37:02 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords EIF4A2
LSCC
RKIP
SERPINE1
TGF-βR1
LncRNA
NR3C1
BZW1
CircRNA
SOX2
HOXA9
PI3K
SOX4
PDGFRA
CPT1A
MDR-1
POSTN
MiRNA
AI
MITF
Snail
DCTD
EGF-L7
PDAC
HNSCC
RBP1
TXNIP
CircRNAs
ERK
ceRNA
ABCB1
YAP
Chk1
HIF1A
IKKε
HBXIP
GSK-3β
PD-L1
ATG5
SMAD2
OSCC
KLHL21
HMGA2
NETO2
PAICS
HNRNPK
SP1
ZEB
MDM2
NF1
TCF3
ATR
Cancer
TAM
FEN1
HNF4G
PTEN
LAMC2
BRCA1
ALDH1
LTBP-1
DNMT3B
mTOR
OLR1
P-gp
MMP2
HCC
TET1
FOXL2
MAPK
ESCC
LATS1
PCL
MET
PTC
Bcl-2
VEGFR2
NF-κB1
ROCK1
THBS2
CBP
ER-α36
BCLAF1
GBM
MTA1
U2AF2
TP53INP1
E2F1
Foxi1
PP4R1
AP1
Tgfbr3
STAT3
NcRNA
HN1
TME
FAK
PEG
PLGA
APC
KRT17
PEI
eIF5A2
Language English
License This is an open access article under the CC BY license.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-41e0ea13d0f27570dbe505c0b8c462b2bdc9940ec6e862c854d9b67c75d5a3e63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1043661823000889
PMID 36931542
PQID 2792904826
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_951253fb7e694aa19f732c9239f6cb49
proquest_miscellaneous_2792904826
pubmed_primary_36931542
crossref_citationtrail_10_1016_j_phrs_2023_106732
crossref_primary_10_1016_j_phrs_2023_106732
elsevier_sciencedirect_doi_10_1016_j_phrs_2023_106732
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2023
2023-04-00
20230401
2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: April 2023
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Pharmacological research
PublicationTitleAlternate Pharmacol Res
PublicationYear 2023
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Fusco, Fedele (bib7) 2007; 7
Xiao, Zhang, Zhan, Yin, Ma, Wei (bib155) 2021; 13
Shi, Wu, Tang, Li, Chen, Xue (bib237) 2016; 41
Ma, Li, Kong, Yang, Yang, Ma (bib234) 2018; 37
Wu, Zhang, Shan, Hu, Liu, Chen (bib193) 2016; 376
Liu, Hu, Zhao, Zhao, Pan (bib338) 2022; 11
Segal, Biscans, Gilles, Anastasiadou, De Luca, Lim (bib186) 2020; 19
Zhang, Mo, Wang (bib32) 2019; 55
Li, Zhang, Cui, Wu, Wang (bib123) 2021; 20
Huang, Li, Guo, Zhao, Yuan (bib153) 2016; 81
Wang, Zhang, Li, Zhao (bib199) 2018; 38
Rajeswari, Jain (bib29) 2002
Yu, Tu, Deng, Guo, Ning, Zhu (bib120) 2016; 17
Tang, Xu, Wang, Niu, Zhu, Lin (bib198) 2018; 11
Tamai, Tatarano, Okamura, Fukumoto, Kawakami, Osako (bib323) 2022; 16
Zhou, Xu, Xia, Gao, Huang, Tang (bib61) 2019; 497
Hui, Yang, Li, Wang, Di, Zhang (bib68) 2020; 29
Ma, Nong, Zhu, Wang, Huang, Yuan (bib106) 2014; 35
Paskeh, Ghadyani, Hashemi, Abbaspour, Zabolian, Javanshir (bib46) 2022
Zhang, Wang, Ding, Liu, Wang, Ding (bib285) 2017; 8
Yu, Lim, Tjokro, Sathiyanathan, Natarajan, Chew (bib6) 2014; 6
Xi, Xin, Ye (bib225) 2014; 7
Li, Shen, Wang, Zhou (bib288) 2019; 158
Hou, Wan, Wang, Li, Wang, Yao (bib299) 2016; 8
Xue F., Feng H., Wang T., Feng G., Ni N., Wang R., et al. hsa_circ_0000264 promotes tumor progression via the hsa‐let‐7b‐5p/HMGA2 axis in head and neck squamous cell carcinoma. Oral Diseases, 2022.
Song, Yang, Liu (bib296) 2016; 20
Huang, Zhang, Jin, Li, Hu, Li (bib240) 2020; 24
Zhao, Zhang, Jiao, Tang (bib138) 2016; 14
Zeng, Zhao, Rao, Hua, Yang, Miao (bib190) 2020; 121
Raskin, Fullen, Giordano, Thomas, Frohm, Cha (bib298) 2013; 133
Liu, Lü, Jiang, Yang, Dang, Sun (bib56) 2019; 34
Gan, Liu, Zhang, He, Bai, Liao (bib24) 2022; 54
Cai, Nie, Chen, Yu (bib60) 2020; 8
Wang, Wang, Zhao, Wang, Chen, Wu (bib111) 2022; 12
Jiang, Cao, Lei, Wang, Fu, Wang (bib181) 2018; 17
Li, Wang, Li, Long, Guo, Zhang (bib213) 2017; 105
Ma, Wu, Zhou, Yin, Xiao (bib277) 2020; 40
Wang, Jia, Diao, He, Jia (bib93) 2020; 28
Wang, Chen, Zhao, Yang, Li, Zhang (bib161) 2017; 292
Shi, Jia, Wen (bib235) 2020; 12
Zhao, Zhao, Xia, Liu (bib308) 2018; 17
Yu, Sun, Jiang, Xu (bib57) 2019; 17
Yang, Zhang, Bo, Hou, Cai, Chen (bib217) 2011; 37
Ros, Pegoraro, De Angelis, Sgarra, Zucchelli, Gustincich (bib80) 2020; 9
Sun, Xu, Liu, Ming (bib180) 2017; 16
Mansoori, Terp, Mohammadi, Pedersen, Ditzel, Baradaran (bib191) 2021; 13
Wang, Cao, Zhou, Wei, Zhan, Fu (bib230) 2018; 10
Agostini, Brunetti, Davidson, Tropé, Heim, Panagopoulos (bib226) 2017; 8
Wu, Xu, Gong, Zhang, Wu (bib202) 2021; 59
Xin, Lin, Wang, Yin, Mahato (bib351) 2019; 11
Wu, Zhao, Tan, Wang, Shen (bib339) 2019; 18
Li, Wei, Zhang, Xu, Che (bib187) 2020; 20
Mei, Wang, Qiu, Xie, Bai, Shi (bib132) 2017; 12
Halder, Pradhan, Kar, Ghosh, Rath (bib317) 2022; 40
Wang, Wang, Cao, Li, Duan, Yuan (bib204) 2019; 11
Y-t, X-b, Liu (bib251) 2016; 6
Li, Wu (bib20) 2023; 9
Zhang, Ren, Hao, Ma, Xin, Jia (bib49) 2018; 10
Ye, Liu, Tang, Xin, Bao, Yan (bib128) 2021; 21
Xu, Chen, Liu, Li, Wu, Zhou (bib136) 2020; 24
Li, Peng, Ning, Jiang, Peng, Ding (bib162) 2020; 121
Fedele, Pierantoni, Visone, Fusco (bib34) 2006; 1
Zhang, Wang (bib53) 2020; 13
Zhu, Hu, Wang, Ding, Li, Wang (bib322) 2022
Bian, Zhang, Li, Feng, Wang, Zhang (bib62) 2018; 24
Wang, Tan, Chen, Zhu, Zhu, Sun (bib263) 2022; 1511
Tang, Liu, Chen, He, Pan, Li (bib347) 2022; 67
Liu, Zhu, Ge (bib100) 2020; 20
Wu, Ai, Zhang, Yun, Xie (bib158) 2019; 12
Zhang, Wu, Wang, Liu (bib254) 2019; 18
Zhu, Wang, Wang, Li, Qiu (bib363) 2021; 21
Hou, Shi, Guo, Zhao, Zhang, Ma (bib17) 2023
Chen, Wang, Zong, Zhou, Chen (bib90) 2022; 13
Fan, Lin, Mao, Huang, Liu, Ma (bib118) 2016; 7
Sadrkhanloo, Entezari, Rashidi, Hashemi, Raesi, Saghari (bib38) 2022; 932
Ma, Zhao, Xue, Gao, Xu (bib295) 2021; 73
Zhang, Wang, Yin, Li, Wu (bib122) 2018; 22
Chen, Guo, Xu, Yang, Wang, Peng (bib63) 2016; 7
Ding, Wang, Ma, Guo, Yan, Chi (bib216) 2014; 47
Kaur, Ali, Huey, Hütt-Cabezas, Taylor, Mao (bib243) 2016; 377
Song, Liao, Yao, Xu, Shen, Tian (bib366) 2022
Wu, Huang, Yang, Xu (bib95) 2019; 65
Cai, Zhang, Wu, Yang, Ye, Chen (bib267) 2018; 140
Gao, Wang, Wang, Zhao (bib179) 2018; 22
Zare, Pemmada, Madhavan, Shailaja, Ramakrishna, Kandiyil (bib344) 2022; 14
Wang, Liang, Ge, Guo, Gu, Yuan (bib147) 2019; 19
He, Guan, Liao, Wu, Liu, Mo (bib289) 2021; 14
Chang, Xiao, Zhu, Ding, Liao, Wang (bib21) 2023
Seo, Kim, Chae, Kim (bib142) 2020; 18
Li, Wang, Zhang, Zhang, Xu, Zhao (bib301) 2019; 25
Deng, Huang, Chen, Tang, Huang, Li (bib160) 2020; 13
Yang, Xiong, Feng, Zhao, Qiu, Liu (bib81) 2020; 18
(bib248) 2021
Wu, Wu, Li, Mo, Lin, Wang (bib304) 2015; 13
Gao, Lu, Lou, Wang, Xu (bib306) 2019; 234
Peng, Wu, Li, Xu, Zhang, Liu (bib252) 2016; 1644
Agostini, Panagopoulos, Andersen, Johannesen, Davidson, Tropé (bib280) 2015; 33
Zhang, Liu, Jin, Chen, Guo (bib319) 2022; 21
Hou, Ishinaga, Midorikawa, Nakamura, Hiraku, Oikawa (bib278) 2018; 9
Jing, Xie, Ding, Xu, Fang, Ma (bib335) 2022; 12
Li, Di, Cong, Wang, Wang (bib177) 2018; 22
Wu, Yao, Yun, Wang, Zhu (bib334) 2019; 39
Jiang, Zhang, Guo, Liu, Wang, Ren (bib357) 2021; 21
Zhou, Xu, Dong, Wang, Duan, Yan (bib85) 2020; 24
Tao, Wan, Fan, Wang, Sun, Ma (bib73) 2020; 52
Wang, Chen, Yu, Song, Li, Shen (bib76) 2020; 27
Xu, Wang, Deng, Liu, Wu, Lai (bib112) 2018; 9
Sun (bib311) 2016; 380
Gasiulė, Dreize, Kaupinis, Ražanskas, Čiupas, Stankevičius (bib337) 2019; 8
He (bib64) 2017; 95
Ho, Chen, Cheuk, Siu, Shin, Kwong (bib326) 2022; 14
Wang, Zhang, Wang, Zhang, Sun, Yang (bib229) 2021
Fatalska, Rusetska, Bakuła-Zalewska, Kowalik, Zięba, Wroblewska (bib281) 2020; 13
Hashemi, Hasani, Hajimazdarany, Ghadyani, Olyaee, Khodadadi (bib52) 2023
Ramos, Bentires-Alj (bib310) 2015; 34
Zhu, Zhang, Chen, Chen, Zheng (bib276) 2019; 117
Dai, Li, Fan, Tan, Wang, Jin (bib182) 2019; 16
Guo, Cheng, Chen, Chen, Xie, Zhao (bib197) 2019; 452
Venkatesan, Kandalam, Pasricha, Sumantran, Manfioletti, Ono (bib300) 2009; 31
Wang, Zhang, Wu, Weng, Zhou, Quan (bib77) 2016; 37
Zhang, Zhang, Yu (bib247) 2018; 7
Entezari, Taheriazam, Orouei, Fallah, Sanaei, Hejazi (bib8) 2022; 154
Lulli, Buccarelli, Ilari, Castellani, De Dominicis, Di, Giamberardino (bib250) 2020; 21
Zhang, Sun, Zhang, Lu, Li, Wei (bib65) 2018; 233
Yang, Cisowski, Nguyen, O'callaghan, Xu, Agarwal (bib192) 2016; 35
Huang, Chen, Zhang (bib41) 2020; 23
Liu, Gong, Xu, Chen, Wang (bib330) 2019; 24
Eun, Kim, Shen, Yang, Kim, Yoon (bib44) 2018; 244
Wu, Tang, Xie, Zheng, Zhang, Mao (bib352) 2020; 10
Kou, Liu, Li, Li, Zhong, Gui (bib143) 2019; 27
Li, Zhao, Zhang, Zhang, Ding, Su (bib167) 2017; 39
Hashemi, Hasani, Hajimazdarany, Mirmazloomi, Makvandy, Zabihi (bib10) 2022
Lu, Huang, Wang, Liu (bib127) 2022; 171
Xia, Lv, Jiang, Li, Li, He (bib58) 2021; 40
Yang, Zhao, Yin, Lei, Gan (bib358) 2017; 25
Li, Jiang, Niu (bib78) 2017; 23
Han, Han, Li, Sun (bib159) 2019; 18
Nadaradjane, Briand, Bougras-Cartron, Disdero, Vallette, Frenel (bib253) 2018; 13
Miao, Gao, Chen, Chen, Meng, Lou (bib367) 2019; 39
Stafford, McKenna (bib26) 2023; 24
Agostini, Brunetti, Davidson, Trope, Heim, Panagopoulos (bib282) 2016; 7
(bib55) 2021
He, Luo, Qin, Mo (bib22) 2022; 29
Jiao, Liu, Tian (bib139) 2019; 12
Fedele, Visone, De Martino, Troncone, Palmieri, Battista (bib33) 2006; 9
Rao, Xu, Zhang, Liu, Luan, Zhou (bib99) 2021; 12
Wang, Mao, Wang, Xu (bib84) 2020; 19
Meyer B., Loeschke S., Schultze A., Weigel T., Sandkamp M., Goldmann T., et al. HMGA2 overexpression in non‐small cell lung cancer. Molecular Carcinogenesis: Published in cooperation with the University of Texas MD Anderson Cancer Center, 2007;46(7):503–11.
Mahajan, Liu, Gellert, Zou, Yang, Lee (bib222) 2010; 23
Zhou, Guo, Zhao, Wang, Zha, Ding (bib307) 2014; 44
Zheng, Bi, Yang, Hong, Ni, Ma (bib151) 2019; 10
Liu, Mou, Shi, Liu, Chen, Zuo (bib126) 2021; 41
Zhang, Tang, Deng, He, Wu, Liu (bib137) 2017; 23
Goodwin, Sanders, Johns (bib2) 1973; 38
Wada, Goto, Tanaka, Okada, Moriya, Idichi (bib130) 2020; 65
Zhang, Li, Chen, Lu, Zhang (bib50) 2020; 33
Li, Miao, Liu, Zhang, Jin, Luo (bib258) 2017; 8
Bustin, Lehn, Landsman (bib31) 1990; 1049
Zhao, Pan, Deng, Cao, Vicencio, Liu (bib336) 2022
Dong, Wang, Ren, Li, Wang, Sun (bib40) 2017; 23
Dong, Qu (bib283) 2020; 51
Hengjuan, Liu, Kun, Mingqiu, Zhang (bib145) 2019; 74
Zhong, Liu, Li, Cheng, Wang, Tian (bib246) 2016; 7
Wang, Pan, Kang, Shen (bib174) 2020; 59
Xu, Zou, Luo, Wang, Wang (bib149) 2019; 9
Wang, Wu, Zhao, Wang, Huang, Wang (bib266) 2018; 24
Wang, Wang, Wu (bib107) 2021; 14
Li, Gong, Lin, Yao, Yin, Zhou (bib349) 2022; 11
Pan, Tang, Jiang, Li, Wang, Gao (bib59) 2019; 120
Jia, Liu, An, Wang, Wang (bib188) 2022; 235
Sharma, Yadav, Karunagaran (bib232) 2020; 80
Li, Han, Feng, Han (bib70) 2019; 499
Ghafouri-Fard, Dashti, Farsi, Hussen, Taheri (bib69) 2021; 137
Luo, Li, Gao, Long, Chen, Huang (bib87) 2013; 13
Leung, Chou, Huang, Yang (bib109) 2019; 11
Forterre, Komuro, Aminova, Harada (bib12) 2020; 12
Fan, Ye, Wu, Lv, Wu, Xiao (bib259) 2015; 50
Belge, Meyer, Klemke, Burchardt, Stern, Wosniok (bib163) 2008; 47
Su, Li, Chen, Dou, Fang, Luo (bib115) 2020; 24
Palumbo, De Martino, Esposito, Fraggetta, Neto, Valverde Fernandes (bib297) 2018; 72
Gao, Dai, Li, Wang, Lu, Song (bib172) 2017; 8
Xu, Liao, Lu, Li, Yuan, Xu (bib274) 2016; 7
Liu, Wang, Zhao, Liu, Zhang, Gong (bib104) 2022; 40
Golafzani, Vaziri, Javanmardi, Seyfan, Yazdanifar, Khaleghi (bib348) 2022; 37
Liu, Yidayitula, Zhao, Luo, Ma, Xu (bib265) 2018; 25
Deng, Min, Zhou, Yang, Peng, Cui (bib117) 2021; 46
Chiappetta, Ferraro, Vuttariello, Monaco, Galdiero, De Simone (bib166) 2008; 44
Ma, Zhao, Gao, Yao, Zhang, Xu (bib287) 2022; 13
Knutsen, Harris, Perander (bib211) 2022; 126
Ding, Shi, Wu, Man, Han, Cui (bib169) 2022; 13
Yang, Zhang, Zhao, Yang, Jiang, Fan (bib365) 2016; 17
Chen, Liu, Hu, Luo, Zheng (bib96) 2019; 12
Ge, Zheng, Li, Niu, Li (bib291) 2016; 11
Zhou, Li, Xie, Wu, Lin, He (bib110) 2020; 13
Xu, Zhao, Gao, Ni, Wang, Hu (bib92) 2021; 86
Gao, Zhang, Liu, Li (bib332) 2019; 9
Han, Zhang, Wang, Li, Wang, Li (bib341) 2021; 15
Sakata, Hirosue, Yoshida, Kawahara, Matsuoka, Yamamoto (bib268) 2019; 20
Ma, Gao, Zhang, Yao, Jia, Xu (bib290) 2021; 35
Malek, Bakhidze, Noske, Sers, Aigner, Schäfer (bib224) 2008; 123
Jia, Zhu, Yang, Ma, Pu, Han (bib369) 2020; 24
Zou, Wu, Fu, Yi, Pei, Zhou (bib200) 2016; 610
Liang, Zhu
Zhang (10.1016/j.phrs.2023.106732_bib65) 2018; 233
Kumar (10.1016/j.phrs.2023.106732_bib176) 2014; 505
Asuthkar (10.1016/j.phrs.2023.106732_bib257) 2012; 3
Wu (10.1016/j.phrs.2023.106732_bib339) 2019; 18
10.1016/j.phrs.2023.106732_bib279
Liang (10.1016/j.phrs.2023.106732_bib359) 2021; 20
Zheng (10.1016/j.phrs.2023.106732_bib151) 2019; 10
Sun (10.1016/j.phrs.2023.106732_bib184) 2019; 19
Califano (10.1016/j.phrs.2023.106732_bib223) 2014; 229
Wang (10.1016/j.phrs.2023.106732_bib263) 2022; 1511
Tang (10.1016/j.phrs.2023.106732_bib347) 2022; 67
Dharavath (10.1016/j.phrs.2023.106732_bib18) 2023; 6
Leung (10.1016/j.phrs.2023.106732_bib109) 2019; 11
Knutsen (10.1016/j.phrs.2023.106732_bib211) 2022; 126
Li (10.1016/j.phrs.2023.106732_bib349) 2022; 11
Ma (10.1016/j.phrs.2023.106732_bib290) 2021; 35
Lang (10.1016/j.phrs.2023.106732_bib23) 2022; 8
Bai (10.1016/j.phrs.2023.106732_bib214) 2021; 23
Deng (10.1016/j.phrs.2023.106732_bib117) 2021; 46
Zhang (10.1016/j.phrs.2023.106732_bib247) 2018; 7
Park (10.1016/j.phrs.2023.106732_bib342) 2022; 12
Bustin (10.1016/j.phrs.2023.106732_bib1) 1996; 54
Yang (10.1016/j.phrs.2023.106732_bib192) 2016; 35
Y-t (10.1016/j.phrs.2023.106732_bib251) 2016; 6
Ros (10.1016/j.phrs.2023.106732_bib80) 2020; 9
Holohan (10.1016/j.phrs.2023.106732_bib315) 2013; 13
Jing (10.1016/j.phrs.2023.106732_bib335) 2022; 12
Hou (10.1016/j.phrs.2023.106732_bib17) 2023
Ge (10.1016/j.phrs.2023.106732_bib291) 2016; 11
Yang (10.1016/j.phrs.2023.106732_bib365) 2016; 17
Zhang (10.1016/j.phrs.2023.106732_bib53) 2020; 13
Liu (10.1016/j.phrs.2023.106732_bib256) 2019; 38
Ramos (10.1016/j.phrs.2023.106732_bib310) 2015; 34
Wu (10.1016/j.phrs.2023.106732_bib360) 2016; 5
Ding (10.1016/j.phrs.2023.106732_bib216) 2014; 47
Fedele (10.1016/j.phrs.2023.106732_bib33) 2006; 9
He (10.1016/j.phrs.2023.106732_bib206) 2022; 30
Li (10.1016/j.phrs.2023.106732_bib187) 2020; 20
Hashemi (10.1016/j.phrs.2023.106732_bib10) 2022
Tamai (10.1016/j.phrs.2023.106732_bib323) 2022; 16
Yang (10.1016/j.phrs.2023.106732_bib81) 2020; 18
Fan (10.1016/j.phrs.2023.106732_bib259) 2015; 50
Jiao (10.1016/j.phrs.2023.106732_bib139) 2019; 12
Cantile (10.1016/j.phrs.2023.106732_bib205) 2020; 12
Song (10.1016/j.phrs.2023.106732_bib366) 2022
Belge (10.1016/j.phrs.2023.106732_bib163) 2008; 47
Gao (10.1016/j.phrs.2023.106732_bib172) 2017; 8
Liang (10.1016/j.phrs.2023.106732_bib116) 2019; 10
Nie (10.1016/j.phrs.2023.106732_bib350) 2020; 12
Hajibabaei (10.1016/j.phrs.2023.106732_bib19) 2023; 13
Wang (10.1016/j.phrs.2023.106732_bib76) 2020; 27
Ma (10.1016/j.phrs.2023.106732_bib295) 2021; 73
Jia (10.1016/j.phrs.2023.106732_bib369) 2020; 24
Zhang (10.1016/j.phrs.2023.106732_bib133) 2021; 51
Hui (10.1016/j.phrs.2023.106732_bib68) 2020; 29
Chen (10.1016/j.phrs.2023.106732_bib90) 2022; 13
Hashemi (10.1016/j.phrs.2023.106732_bib47) 2022
Wu (10.1016/j.phrs.2023.106732_bib304) 2015; 13
Zhou (10.1016/j.phrs.2023.106732_bib61) 2019; 497
Wang (10.1016/j.phrs.2023.106732_bib231) 2018; 9
Zhu (10.1016/j.phrs.2023.106732_bib363) 2021; 21
Mo (10.1016/j.phrs.2023.106732_bib156) 2019; 120
Holjencin (10.1016/j.phrs.2023.106732_bib343) 2022; 11
Deng (10.1016/j.phrs.2023.106732_bib108) 2021; 12
Li (10.1016/j.phrs.2023.106732_bib288) 2019; 158
Palumbo (10.1016/j.phrs.2023.106732_bib297) 2018; 72
Jang (10.1016/j.phrs.2023.106732_bib324) 2022; 29
Grosschedl (10.1016/j.phrs.2023.106732_bib30) 1994; 10
Bustin (10.1016/j.phrs.2023.106732_bib31) 1990; 1049
Tong (10.1016/j.phrs.2023.106732_bib97) 2020; 24
Jiang (10.1016/j.phrs.2023.106732_bib181) 2018; 17
Dong (10.1016/j.phrs.2023.106732_bib283) 2020; 51
Xia (10.1016/j.phrs.2023.106732_bib302) 2015; 8
Huang (10.1016/j.phrs.2023.106732_bib240) 2020; 24
Forterre (10.1016/j.phrs.2023.106732_bib12) 2020; 12
Segal (10.1016/j.phrs.2023.106732_bib186) 2020; 19
Lu (10.1016/j.phrs.2023.106732_bib327) 2020; 39
Dong (10.1016/j.phrs.2023.106732_bib40) 2017; 23
Lappinga (10.1016/j.phrs.2023.106732_bib165) 2010; 118
Li (10.1016/j.phrs.2023.106732_bib39) 2017; 37
Jiménez-Morales (10.1016/j.phrs.2023.106732_bib249) 2022; 349
Pan (10.1016/j.phrs.2023.106732_bib59) 2019; 120
Ma (10.1016/j.phrs.2023.106732_bib106) 2014; 35
Chen (10.1016/j.phrs.2023.106732_bib121) 2021
Li (10.1016/j.phrs.2023.106732_bib162) 2020; 121
Cui (10.1016/j.phrs.2023.106732_bib150) 2018; 8
Narita (10.1016/j.phrs.2023.106732_bib5) 2006; 126
Wu (10.1016/j.phrs.2023.106732_bib158) 2019; 12
Luo (10.1016/j.phrs.2023.106732_bib87) 2013; 13
10.1016/j.phrs.2023.106732_bib113
Xiao (10.1016/j.phrs.2023.106732_bib155) 2021; 13
Hou (10.1016/j.phrs.2023.106732_bib27) 2022; 43
Song (10.1016/j.phrs.2023.106732_bib296) 2016; 20
Wang (10.1016/j.phrs.2023.106732_bib314) 2019; 2
Ye (10.1016/j.phrs.2023.106732_bib309) 2022
Han (10.1016/j.phrs.2023.106732_bib341) 2021; 15
Rao (10.1016/j.phrs.2023.106732_bib99) 2021; 12
Lu (10.1016/j.phrs.2023.106732_bib127) 2022; 171
Wang (10.1016/j.phrs.2023.106732_bib161) 2017; 292
Yang (10.1016/j.phrs.2023.106732_bib217) 2011; 37
Nadaradjane (10.1016/j.phrs.2023.106732_bib253) 2018; 13
Zhao (10.1016/j.phrs.2023.106732_bib209) 2018; 7
Wu (10.1016/j.phrs.2023.106732_bib67) 2017; 96
Agostini (10.1016/j.phrs.2023.106732_bib280) 2015; 33
Li (10.1016/j.phrs.2023.106732_bib43) 2019; 19
Fedele (10.1016/j.phrs.2023.106732_bib34) 2006; 1
Wu (10.1016/j.phrs.2023.106732_bib193) 2016; 376
Zhang (10.1016/j.phrs.2023.106732_bib88) 2019; 19
10.1016/j.phrs.2023.106732_bib105
(10.1016/j.phrs.2023.106732_bib218) 2019
Li (10.1016/j.phrs.2023.106732_bib213) 2017; 105
Jordan-Alejandre (10.1016/j.phrs.2023.106732_bib15) 2023; 12
Zhang (10.1016/j.phrs.2023.106732_bib32) 2019; 55
Gong (10.1016/j.phrs.2023.106732_bib28) 2022; 23
Jiang (10.1016/j.phrs.2023.106732_bib357) 2021; 21
Xia (10.1016/j.phrs.2023.106732_bib303) 2015; 463
Sun (10.1016/j.phrs.2023.106732_bib311) 2016; 380
Lee (10.1016/j.phrs.2023.106732_bib178) 2007; 21
Shi (10.1016/j.phrs.2023.106732_bib235) 2020; 12
Li (10.1016/j.phrs.2023.106732_bib340) 2020; 12
Wu (10.1016/j.phrs.2023.106732_bib95) 2019; 65
Luo (10.1016/j.phrs.2023.106732_bib144) 2013; 5
Ma (10.1016/j.phrs.2023.106732_bib234) 2018; 37
Huang (10.1016/j.phrs.2023.106732_bib255) 2015; 6
Chen (10.1016/j.phrs.2023.106732_bib114) 2019; 10
Ding (10.1016/j.phrs.2023.106732_bib169) 2022; 13
Wu (10.1016/j.phrs.2023.106732_bib362) 2019; 8
Yang (10.1016/j.phrs.2023.106732_bib358) 2017; 25
He (10.1016/j.phrs.2023.106732_bib64) 2017; 95
Goodwin (10.1016/j.phrs.2023.106732_bib2) 1973; 38
Fernandez-Piñeiro (10.1016/j.phrs.2023.106732_bib14) 2017; 35
Wang (10.1016/j.phrs.2023.106732_bib77) 2016; 37
Huang (10.1016/j.phrs.2023.106732_bib153) 2016; 81
Han (10.1016/j.phrs.2023.106732_bib189) 2020; 12
Zhou (10.1016/j.phrs.2023.106732_bib110) 2020; 13
Sun (10.1016/j.phrs.2023.106732_bib195) 2013; 110
Zhou (10.1016/j.phrs.2023.106732_bib245) 2021; 14
Cai (10.1016/j.phrs.2023.106732_bib267) 2018; 140
Gao (10.1016/j.phrs.2023.106732_bib332) 2019; 9
Kleemann (10.1016/j.phrs.2023.106732_bib227) 2019; 76
Jiang (10.1016/j.phrs.2023.106732_bib98) 2016; 16
Tang (10.1016/j.phrs.2023.106732_bib198) 2018; 11
Conte (10.1016/j.phrs.2023.106732_bib353) 2020; 21
Li (10.1016/j.phrs.2023.106732_bib271) 2022; 418
Halder (10.1016/j.phrs.2023.106732_bib317) 2022; 40
Šamija (10.1016/j.phrs.2023.106732_bib164) 2019; 27
Li (10.1016/j.phrs.2023.106732_bib328) 2022; 109
Xu (10.1016/j.phrs.2023.106732_bib185) 2018; 7
Wang (10.1016/j.phrs.2023.106732_bib101) 2022
Xu (10.1016/j.phrs.2023.106732_bib112) 2018; 9
Kolliopoulos (10.1016/j.phrs.2023.106732_bib196) 2019; 80
Wu (10.1016/j.phrs.2023.106732_bib202) 2021; 59
Agostini (10.1016/j.phrs.2023.106732_bib226) 2017; 8
Che (10.1016/j.phrs.2023.106732_bib134) 2022; 33
Wei (10.1016/j.phrs.2023.106732_bib233) 2016; 6
Li (10.1016/j.phrs.2023.106732_bib167) 2017; 39
Mei (10.1016/j.phrs.2023.106732_bib132) 2017; 12
Wang (10.1016/j.phrs.2023.106732_bib230) 2018; 10
Ma (10.1016/j.phrs.2023.106732_bib286) 2021; 58
Wu (10.1016/j.phrs.2023.106732_bib352) 2020; 10
Wang (10.1016/j.phrs.2023.106732_bib48) 2017; 23
Li (10.1016/j.phrs.2023.106732_bib123) 2021; 20
Cai (10.1016/j.phrs.2023.106732_bib238) 2016; 37
Yu (10.1016/j.phrs.2023.106732_bib120) 2016; 17
Jia (10.1016/j.phrs.2023.106732_bib188) 2022; 235
Qin (10.1016/j.phrs.2023.106732_bib203) 2020; 28
Agostini (10.1016/j.phrs.2023.106732_bib282) 2016; 7
Zhang (10.1016/j.phrs.2023.106732_bib49) 2018; 10
Kang (10.1016/j.phrs.2023.106732_bib131) 2018; 22
Peng (10.1016/j.phrs.2023.106732_bib355) 2021; 9
Chang (10.1016/j.phrs.2023.106732_bib21) 2023
Zhang (10.1016/j.phrs.2023.106732_bib285) 2017; 8
Chen (10.1016/j.phrs.2023.106732_bib96) 2019; 12
Venkatesan (10.1016/j.phrs.2023.106732_bib300) 2009; 31
Xi (10.1016/j.phrs.2023.106732_bib225) 2014; 7
Qiu (10.1016/j.phrs.2023.106732_bib220) 2022; 41
Kaur (10.1016/j.phrs.2023.106732_bib243) 2016; 377
Hashemi (10.1016/j.phrs.2023.106732_bib103) 2022; 184
Xia (10.1016/j.phrs.2023.106732_bib58) 2021; 40
Liu (10.1016/j.phrs.2023.106732_bib330) 2019; 24
Su (10.1016/j.phrs.2023.106732_bib115) 2020; 24
He (10.1016/j.phrs.2023.106732_bib289) 2021; 14
Zhang (10.1016/j.phrs.2023.106732_bib122) 2018; 22
Zou (10.1016/j.phrs.2023.106732_bib200) 2016; 610
(10.1016/j.phrs.2023.106732_bib248) 2021
Xin (10.1016/j.phrs.2023.106732_bib351) 2019; 11
Chen (10.1016/j.phrs.2023.106732_bib63) 2016; 7
Wang (10.1016/j.phrs.2023.106732_bib229) 2021
Sadrkhanloo (10.1016/j.phrs.2023.106732_bib38) 2022; 932
Zhu (10.1016/j.phrs.2023.106732_bib276) 2019; 117
Wang (10.1016/j.phrs.2023.106732_bib174) 2020; 59
Hawsawi (10.1016/j.phrs.2023.106732_bib239) 2018; 504
Rajeswari (10.1016/j.phrs.2023.106732_bib29) 2002
Xiong (10.1016/j.phrs.2023.106732_bib140) 2020; 35
Li (10.1016/j.phrs.2023.106732_bib78) 2017; 23
He (10.1016/j.phrs.2023.106732_bib22) 2022; 29
Zhang (10.1016/j.phrs.2023.106732_bib72) 2021; 12
Guo (10.1016/j.phrs.2023.106732_bib83) 2020; 393
Ma (10.1016/j.phrs.2023.106732_bib236) 2021; 24
Li (10.1016/j.phrs.2023.106732_bib20) 2023; 9
Sun (10.1016/j.phrs.2023.106732_bib35) 2017; 7
Fang (10.1016/j.phrs.2023.106732_bib273) 2017; 37
Ganju (10.1016/j.phrs.2023.106732_bib13) 2017; 22
Yu (10.1016/j.phrs.2023.106732_bib86) 2022; 14
Ou (10.1016/j.phrs.2023.106732_bib146) 2017; 13
Qiu (10.1016/j.phrs.2023.106732_bib329) 2020; 46
Ye (10.10
References_xml – volume: 7
  start-page: 899
  year: 2007
  end-page: 910
  ident: bib7
  article-title: Roles of HMGA proteins in cancer
  publication-title: Nat. Rev. Cancer
– volume: 18
  start-page: 664
  year: 2019
  end-page: 670
  ident: bib254
  article-title: miR‑490–3p functions as a tumor suppressor in glioma by inhibiting high‑mobility group AT‑hook 2 expression
  publication-title: Exp. Ther. Med.
– volume: 37
  start-page: 1891
  year: 2017
  end-page: 1899
  ident: bib273
  article-title: High HMGA2 expression correlates with reduced recurrence-free survival and poor overall survival in oral squamous cell carcinoma
  publication-title: Anticancer Res.
– volume: 52
  start-page: 773
  year: 2020
  end-page: 779
  ident: bib73
  article-title: Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis
  publication-title: Dig. Liver Dis.
– volume: 29
  year: 2020
  ident: bib68
  article-title: LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR-363-3p/HMGA2
  publication-title: Cell Transplant.
– volume: 27
  start-page: 1
  year: 2022
  end-page: 29
  ident: bib320
  article-title: CRISPR/Cas9 gene editing: A new approach for overcoming drug resistance in cancer
  publication-title: Cell. Mol. Biol. Lett.
– volume: 9
  start-page: 1526
  year: 2020
  ident: bib80
  article-title: HMGA2 antisense long non-coding RNAs as new players in the regulation of HMGA2 expression and pancreatic cancer promotion
  publication-title: Front. Oncol.
– volume: 12
  start-page: 963
  year: 2022
  ident: bib111
  article-title: HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment
  publication-title: Theranostics
– volume: 10
  start-page: 6037
  year: 2019
  ident: bib116
  article-title: Dichloroacetate overcomes oxaliplatin chemoresistance in colorectal cancer through the miR-543/PTEN/Akt/mTOR pathway
  publication-title: J. Cancer
– volume: 16
  start-page: 675
  year: 2019
  end-page: 685
  ident: bib182
  article-title: miR-150-5p inhibits non-small-cell lung cancer metastasis and recurrence by targeting HMGA2 and β-catenin signaling
  publication-title: Mol. Ther. -Nucleic Acids
– volume: 64
  start-page: 496
  year: 2020
  end-page: 497
  ident: bib262
  article-title: MicroRNA-98 promotes cell proliferation and invasion of glioblastoma via targeting HMGA2
  publication-title: J. Neurosurg. Sci.
– volume: 308
  start-page: 44
  year: 2019
  end-page: 56
  ident: bib356
  article-title: Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models
  publication-title: J. Control. Release
– volume: 21
  start-page: 47
  year: 2022
  ident: bib319
  article-title: Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
  publication-title: Mol. Cancer
– volume: 463
  start-page: 357
  year: 2015
  end-page: 363
  ident: bib303
  article-title: Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 24
  start-page: 5391
  year: 2020
  end-page: 5403
  ident: bib136
  article-title: LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 28
  start-page: 483
  year: 2020
  ident: bib203
  article-title: Long noncoding RNA LINC02163 accelerates malignant tumor behaviors in breast cancer by regulating the MicroRNA-511-3p/HMGA2 axis
  publication-title: Oncol. Res.
– volume: 120
  year: 2019
  ident: bib156
  article-title: LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression
  publication-title: Biomed. Pharmacother.
– volume: 50
  start-page: 58.5
  year: 2015
  ident: bib259
  article-title: Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε
  publication-title: Age (years)
– volume: 12
  year: 2022
  ident: bib335
  article-title: Exosome‐transmitted miR‐769–5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53
  publication-title: Clin. Transl. Med.
– volume: 393
  year: 2020
  ident: bib83
  article-title: High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN
  publication-title: Exp. Cell Res.
– volume: 11
  start-page: 11937
  year: 2019
  ident: bib135
  article-title: Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma
  publication-title: Aging (Albany NY)
– start-page: 1
  year: 2023
  end-page: 14
  ident: bib17
  article-title: HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway
  publication-title: Gastric Cancer
– volume: 34
  start-page: 3617
  year: 2015
  end-page: 3626
  ident: bib310
  article-title: Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
  publication-title: Oncogene
– volume: 8
  start-page: 2115
  year: 2019
  ident: bib337
  article-title: Molecular insights into miRNA-driven resistance to 5-fluorouracil and oxaliplatin chemotherapy: miR-23b modulates the epithelial–mesenchymal transition of colorectal cancer cells
  publication-title: J. Clin. Med.
– volume: 121
  start-page: 3814
  year: 2020
  end-page: 3824
  ident: bib190
  article-title: Knockdown of lncRNA ZFAS1–suppressed non–small cell lung cancer progression via targeting the miR‐150–5p/HMGA2 signaling
  publication-title: J. Cell. Biochem.
– year: 2019
  ident: bib218
  article-title: Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
  publication-title: Urologic Oncology: Seminars and Original Investigations
– volume: 21
  start-page: 869
  year: 2020
  ident: bib353
  article-title: Cationic polymer nanoparticles-mediated delivery of miR-124 impairs tumorigenicity of prostate cancer cells
  publication-title: Int. J. Mol. Sci.
– volume: 27
  start-page: 1
  year: 2022
  end-page: 25
  ident: bib318
  article-title: The role of epigenetic modifications in drug resistance and treatment of breast cancer
  publication-title: Cell. Mol. Biol. Lett.
– volume: 140
  start-page: 225
  year: 2018
  end-page: 236
  ident: bib267
  article-title: Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway
  publication-title: J. Neuro-Oncol.
– volume: 12
  start-page: 1
  year: 2020
  end-page: 19
  ident: bib316
  article-title: DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
  publication-title: Clin. Epigenet.
– volume: 13
  start-page: 642
  year: 2018
  end-page: 650
  ident: bib253
  article-title: miR-370-3p is a therapeutic tool in anti-glioblastoma therapy but is not an intratumoral or cell-free circulating biomarker
  publication-title: Mol. Ther. -Nucleic Acids
– volume: 74
  start-page: 301
  year: 2019
  end-page: 304
  ident: bib145
  article-title: Angiogenin regulates epithelial-mesenchymal transition of hepatocellular carcinoma through upregulation of HMGA2. Die Pharmazie-An
  publication-title: Int. J. Pharm. Sci.
– volume: 9
  start-page: 1784
  year: 2019
  end-page: 1797
  ident: bib149
  article-title: Micro RNA‐9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA 2
  publication-title: FEBS Open Bio
– volume: 118
  start-page: 287
  year: 2010
  end-page: 297
  ident: bib165
  article-title: HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules
  publication-title: Cancer Cytopathol.
– volume: 19
  start-page: 1
  year: 2019
  end-page: 13
  ident: bib88
  article-title: lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4
  publication-title: Cancer Cell Int.
– volume: 19
  start-page: 1
  year: 2019
  end-page: 12
  ident: bib43
  article-title: MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
  publication-title: Cancer Cell Int.
– volume: 28
  start-page: 2467
  year: 2010
  ident: bib244
  article-title: Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival
  publication-title: J. Clin. Oncol.
– volume: 22
  start-page: 8298
  year: 2018
  end-page: 8305
  ident: bib131
  article-title: MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 7
  start-page: 21825
  year: 2016
  ident: bib118
  article-title: MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2
  publication-title: Oncotarget
– volume: 41
  year: 2021
  ident: bib126
  article-title: Circular RNA 100146 promotes colorectal cancer progression by the MicroRNA 149/HMGA2 Axis
  publication-title: Mol. Cell. Biol.
– volume: 1799
  start-page: 3
  year: 2010
  end-page: 14
  ident: bib4
  article-title: Nuclear functions of the HMG proteins
  publication-title: Biochim. Et. Biophys. Acta (BBA)-Gene Regul. Mech.
– volume: 14
  start-page: 1620
  year: 2022
  ident: bib344
  article-title: Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics
  publication-title: Pharmaceutics
– volume: 41
  start-page: 229
  year: 2016
  end-page: 236
  ident: bib237
  article-title: Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells
  publication-title: J. Biosci.
– start-page: 1
  year: 2022
  end-page: 12
  ident: bib366
  article-title: miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
  publication-title: Cancer Gene Ther.
– volume: 184
  year: 2022
  ident: bib103
  article-title: Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
  publication-title: Pharmacol. Res.
– start-page: 2021
  year: 2021
  ident: bib121
  article-title: MicroRNA-let-7 targets HMGA2 to regulate the proliferation, migration, and invasion of colon cancer cell HCT116
  publication-title: Evid. -Based Complement. Altern. Med.: eCAM
– volume: 48
  start-page: 4858
  year: 2020
  end-page: 4876
  ident: bib129
  article-title: The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt–PCAF pathway in promotion of esophageal squamous cell carcinoma growth
  publication-title: Nucleic Acids Res.
– volume: 497
  start-page: 20
  year: 2019
  end-page: 26
  ident: bib61
  article-title: Long noncoding RNA FEZF1-AS1 in human cancers
  publication-title: Clin. Chim. Acta
– volume: 67
  year: 2022
  ident: bib347
  article-title: Functionalized PAMAM-Based system for targeted delivery of miR-205 and 5-fluorouracil in breast cancer
  publication-title: J. Drug Deliv. Sci. Technol.
– volume: 12
  start-page: 877
  year: 2020
  end-page: 887
  ident: bib350
  article-title: Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer
  publication-title: Nanoscale
– volume: 229
  start-page: 53
  year: 2014
  end-page: 59
  ident: bib223
  article-title: High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer
  publication-title: J. Cell. Physiol.
– volume: 11
  start-page: 5666
  year: 2022
  ident: bib338
  article-title: MicroRNA-155-5p contributes to 5-fluorouracil resistance through down-regulating TP53INP1 in oral squamous cell carcinoma
  publication-title: Front. Oncol.
– volume: 95
  start-page: 331
  year: 2017
  end-page: 338
  ident: bib64
  article-title: hu Zhang F, Shen N. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)
  publication-title: Biomed. Pharmacother.
– reference: Jin W., Zhang H., Li M., Lin S. Long noncoding RNA regulator of reprogramming regulates cell growth, metastasis, and cisplatin resistance in gastric cancer via miR-519d-3p/HMGA2 Axis. Cancer Biotherapy & Radiopharmaceuticals, 2020.
– volume: 126
  start-page: 551
  year: 2022
  end-page: 561
  ident: bib211
  article-title: Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer
  publication-title: Br. J. Cancer
– volume: 21
  start-page: 1
  year: 2021
  end-page: 16
  ident: bib357
  article-title: Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
  publication-title: BMC Cancer
– volume: 20
  start-page: 1
  year: 2022
  end-page: 13
  ident: bib364
  article-title: Knockdown circTRIM28 enhances tamoxifen sensitivity via the miR-409-3p/HMGA2 axis in breast cancer
  publication-title: Reprod. Biol. Endocrinol.
– volume: 37
  start-page: 12867
  year: 2016
  end-page: 12875
  ident: bib77
  article-title: Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion
  publication-title: Tumor Biol.
– volume: 8
  start-page: 501
  year: 2017
  end-page: 510
  ident: bib172
  article-title: HMGA 2 regulates lung cancer proliferation and metastasis
  publication-title: Thorac. Cancer
– volume: 21
  start-page: 1
  year: 2023
  end-page: 26
  ident: bib345
  article-title: The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
  publication-title: Cell Commun. Signal.
– reference: Xue F., Feng H., Wang T., Feng G., Ni N., Wang R., et al. hsa_circ_0000264 promotes tumor progression via the hsa‐let‐7b‐5p/HMGA2 axis in head and neck squamous cell carcinoma. Oral Diseases, 2022.
– volume: 34
  year: 2020
  ident: bib168
  article-title: miR‐98–5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase‐3 by HMGA2
  publication-title: J. Clin. Lab. Anal.
– volume: 13
  start-page: 6629
  year: 2022
  end-page: 6640
  ident: bib169
  article-title: The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
  publication-title: Bioengineered
– reference: Wang C., Long Y., Tao M., Ma H., Li Y., Zhou G., et al. HMGA2 Promotes Colorectal Cancer Angiogenesis via Dual Regulation of Sema3A and VEGFA, 2021.
– volume: 109
  start-page: 93
  year: 2022
  end-page: 100
  ident: bib328
  article-title: MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1
  publication-title: Reprod. Toxicol.
– volume: 23
  start-page: 3461
  year: 2017
  end-page: 3473
  ident: bib40
  article-title: HMGA2–FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric CancerHMGA2–FOXL2 Pathway Promotes Metastases and EMT in GC
  publication-title: Clin. Cancer Res.
– volume: 12
  start-page: 370
  year: 2020
  ident: bib189
  article-title: Long noncoding RNA VPS9D1-AS1 augments the malignant phenotype of non-small cell lung cancer by sponging microRNA-532-3p and thereby enhancing HMGA2 expression
  publication-title: Aging (Albany NY)
– volume: 11
  start-page: 14647
  year: 2019
  end-page: 14659
  ident: bib351
  article-title: ROS-responsive polymeric micelles for triggered simultaneous delivery of PLK1 inhibitor/miR-34a and effective synergistic therapy in pancreatic cancer
  publication-title: ACS Appl. Mater. Interfaces
– volume: 12
  start-page: 11623
  year: 2019
  ident: bib158
  article-title: Long non-coding RNA EGOT promotes the malignant phenotypes of hepatocellular carcinoma cells and increases the expression of HMGA2 via down-regulating miR-33a-5p
  publication-title: OncoTargets Ther.
– volume: 18
  start-page: 4
  year: 2020
  ident: bib142
  article-title: The ceRNA network of lncRNA and miRNA in lung cancer
  publication-title: Genom. Inform.
– volume: 59
  start-page: 467
  year: 2020
  end-page: 477
  ident: bib174
  article-title: PP4R1 interacts with HMGA2 to promote non‐small‐cell lung cancer migration and metastasis via activating MAPK/ERK‐induced epithelial‐mesenchymal transition
  publication-title: Mol. Carcinog.
– volume: 33
  start-page: 2675
  year: 2015
  end-page: 2680
  ident: bib280
  article-title: HMGA2 expression pattern and TERT mutations in tumors of the vulva
  publication-title: Oncol. Rep.
– volume: 20
  start-page: 1
  year: 2020
  end-page: 15
  ident: bib100
  article-title: LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924
  publication-title: Cancer Cell Int.
– volume: 234
  start-page: 21359
  year: 2019
  end-page: 21368
  ident: bib124
  article-title: miRNA‐143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro
  publication-title: J. Cell. Physiol.
– volume: 8
  start-page: 25167
  year: 2017
  ident: bib258
  article-title: Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM
  publication-title: Oncotarget
– volume: 14
  start-page: 3818
  year: 2022
  ident: bib346
  article-title: miRacle of microRNA-Driven Cancer Nanotherapeutics
  publication-title: Cancers
– volume: 46
  start-page: 1
  year: 2021
  end-page: 11
  ident: bib117
  article-title: Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis
  publication-title: Oncol. Rep.
– volume: 44
  start-page: 1015
  year: 2008
  end-page: 1021
  ident: bib166
  article-title: HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
  publication-title: Eur. J. Cancer
– volume: 12
  year: 2017
  ident: bib132
  article-title: miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma
  publication-title: PLoS One
– volume: 54
  start-page: 35
  year: 1996
  end-page: 100b
  ident: bib1
  article-title: High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function
  publication-title: Prog. Nucleic Acid. Res. Mol. Biol.
– volume: 72
  start-page: 1102
  year: 2018
  end-page: 1114
  ident: bib297
  article-title: HMGA 2, but not HMGA 1, is overexpressed in human larynx carcinomas
  publication-title: Histopathology
– volume: 15
  start-page: 2
  year: 2016
  ident: bib183
  article-title: MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer
  publication-title: Genet Mol. Res
– volume: 12
  start-page: 6947
  year: 2019
  ident: bib139
  article-title: microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2
  publication-title: OncoTargets Ther.
– volume: 11
  start-page: 3065
  year: 2022
  ident: bib349
  article-title: Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204
  publication-title: Cells
– volume: 27
  start-page: 173
  year: 2019
  ident: bib143
  article-title: H19 facilitates tongue squamous cell carcinoma migration and invasion via sponging miR-let-7
  publication-title: Oncol. Res.
– volume: 123
  start-page: 348
  year: 2008
  end-page: 356
  ident: bib224
  article-title: HMGA2 gene is a promising target for ovarian cancer silencing therapy
  publication-title: Int. J. Cancer
– volume: 12
  start-page: 1
  year: 2021
  end-page: 17
  ident: bib72
  article-title: METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer
  publication-title: Cell death Dis.
– volume: 51
  start-page: 1
  year: 2018
  end-page: 7
  ident: bib228
  article-title: MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2
  publication-title: Biol. Res.
– volume: 80
  start-page: 29
  year: 2019
  end-page: 45
  ident: bib196
  article-title: Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer
  publication-title: Matrix Biol.
– volume: 12
  start-page: 3013
  year: 2020
  ident: bib152
  article-title: Effect and mechanism of miR-26a-5p on proliferation and apoptosis of hepatocellular carcinoma cells
  publication-title: Cancer Manag. Res.
– volume: 39
  start-page: 234
  year: 2020
  end-page: 247
  ident: bib327
  article-title: MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer
  publication-title: Oncogene
– year: 2022
  ident: bib37
  article-title: Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance
  publication-title: Pharmacol. Res.
– volume: 21
  start-page: 1
  year: 2021
  ident: bib361
  article-title: MicroRNA‑9–5p increases the sensitivity of colorectal cancer cells to 5–fluorouracil by downregulating high mobility group A2 expression
  publication-title: Oncol. Lett.
– volume: 41
  start-page: 1022
  year: 2021
  end-page: 1029
  ident: bib219
  article-title: miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2
  publication-title: Nan Fang. yi ke da xue xue bao= J. South. Med. Univ.
– volume: 20
  start-page: 4452
  year: 2016
  end-page: 4458
  ident: bib296
  article-title: Expression and significances of MiRNA Let-7 and HMGA2 in laryngeal carcinoma
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 152
  start-page: 199
  year: 2015
  end-page: 208
  ident: bib208
  article-title: Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
  publication-title: Breast Cancer Res. Treat.
– volume: 1644
  start-page: 53
  year: 2016
  end-page: 61
  ident: bib252
  article-title: MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin
  publication-title: Brain Res.
– volume: 76
  start-page: 539
  year: 2019
  end-page: 559
  ident: bib227
  article-title: Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5
  publication-title: Cell. Mol. Life Sci.
– volume: 25
  start-page: 17674
  year: 2018
  end-page: 17681
  ident: bib265
  article-title: LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression
  publication-title: Environ. Sci. Pollut. Res.
– volume: 41
  start-page: 1
  year: 2022
  end-page: 15
  ident: bib220
  article-title: Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 13
  start-page: 1
  year: 2015
  end-page: 13
  ident: bib304
  article-title: Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma
  publication-title: J. Transl. Med.
– volume: 24
  start-page: 8812
  year: 2020
  end-page: 8821
  ident: bib115
  article-title: MiR-543 inhibits proliferation and metastasis of human colorectal cancer cells by targeting PLAS3
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 13
  start-page: 1241
  year: 2022
  ident: bib90
  article-title: miR-497-5p-RSPO2 axis inhibits cell growth and metastasis in glioblastoma
  publication-title: J. Cancer
– volume: 185
  year: 2022
  ident: bib9
  article-title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
  publication-title: Pharmacol. Res.
– volume: 51
  start-page: 329
  year: 2020
  end-page: 340
  ident: bib283
  article-title: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
  publication-title: J. Mol. Histol.
– volume: 8
  start-page: 2484
  year: 2019
  end-page: 2495
  ident: bib362
  article-title: Long non‐coding RNA PCAT6 targets miR‐204 to modulate the chemoresistance of colorectal cancer cells to 5–fluorouracil‐based treatment through HMGA2 signaling
  publication-title: Cancer Med.
– volume: 1049
  start-page: 231
  year: 1990
  end-page: 243
  ident: bib31
  article-title: Structural features of the HMG chromosomal proteins and their genes
  publication-title: Biochim. Et. Biophys. Acta (BBA)-Gene Struct. Expr.
– volume: 84
  start-page: 427
  year: 2019
  end-page: 439
  ident: bib331
  article-title: MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer
  publication-title: Cancer Chemother. Pharmacol.
– volume: 23
  start-page: 673
  year: 2010
  end-page: 681
  ident: bib222
  article-title: HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma
  publication-title: Mod. Pathol.
– volume: 13
  start-page: 10489
  year: 2020
  ident: bib110
  article-title: TAGLN and High-mobility Group AT-Hook 2 (HMGA2) complex regulates TGF-β-induced colorectal cancer metastasis
  publication-title: OncoTargets Ther.
– volume: 380
  start-page: 205
  year: 2016
  end-page: 215
  ident: bib311
  article-title: Tumor microenvironment and cancer therapy resistance
  publication-title: Cancer Lett.
– volume: 24
  start-page: 6639
  year: 2020
  end-page: 6646
  ident: bib97
  article-title: LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 28
  start-page: 51
  year: 2020
  ident: bib66
  article-title: The lncRNA FEZF1-AS1 promotes the progression of colorectal cancer through regulating OTX1 and targeting miR-30a-5p
  publication-title: Oncol. Res.
– volume: 8
  start-page: 405
  year: 2018
  ident: bib150
  article-title: MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2
  publication-title: Am. J. Cancer Res.
– start-page: 1
  year: 2022
  end-page: 21
  ident: bib47
  article-title: Targeting PI3K/Akt signaling in prostate cancer therapy
  publication-title: J. Cell Commun. Signal.
– volume: 120
  start-page: 7499
  year: 2019
  end-page: 7505
  ident: bib71
  article-title: LncRNA OIP5–AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer
  publication-title: J. Cell. Biochem.
– volume: 222
  year: 2021
  ident: bib148
  article-title: miR-760 mediated the proliferation and metastasis of hepatocellular carcinoma cells by regulating HMGA2
  publication-title: Pathol. -Res. Pract.
– volume: 235
  year: 2022
  ident: bib188
  article-title: Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2
  publication-title: Pathol. -Res. Pract.
– volume: 35
  start-page: 9163
  year: 2014
  end-page: 9169
  ident: bib106
  article-title: H19 promotes pancreatic cancer metastasis by derepressing let-7’s suppression on its target HMGA2-mediated EMT
  publication-title: Tumor Biol.
– volume: 7
  start-page: 3889
  year: 2017
  ident: bib119
  article-title: Overexpression of miR-194 reverses HMGA2-driven signatures in colorectal cancer
  publication-title: Theranostics
– volume: 16
  start-page: 432
  year: 2016
  end-page: 439
  ident: bib98
  article-title: miRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells
  publication-title: Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. -Anti-Cancer Agents)
– volume: 25
  start-page: 653
  year: 2017
  end-page: 660
  ident: bib358
  article-title: MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression
  publication-title: J. Drug Target.
– volume: 37
  start-page: 7515
  year: 2016
  end-page: 7523
  ident: bib215
  article-title: Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial–mesenchymal transition in bladder cancer
  publication-title: Tumor Biol.
– volume: 14
  start-page: 1
  year: 2021
  ident: bib289
  article-title: Long noncoding RNA CCDC144NL-AS1 promotes the oncogenicity of osteosarcoma by acting as a molecular sponge for microRNA-490-3p and thereby increasing HMGA2 expression
  publication-title: OncoTargets Ther.
– volume: 137
  year: 2021
  ident: bib69
  article-title: A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies
  publication-title: Biomed. Pharmacother.
– volume: 29
  start-page: 803
  year: 2022
  end-page: 813
  ident: bib22
  article-title: MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway
  publication-title: Cancer Gene Ther.
– volume: 14
  start-page: 601
  year: 2021
  ident: bib245
  article-title: Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children
  publication-title: Pharm. Pers. Med.
– volume: 29
  start-page: 1
  year: 2022
  end-page: 20
  ident: bib324
  article-title: MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway
  publication-title: J. Biomed. Sci.
– volume: 21
  start-page: 1
  year: 2021
  end-page: 19
  ident: bib128
  article-title: LINC00963 affects the development of colorectal cancer via MiR-532-3p/HMGA2 axis
  publication-title: Cancer Cell Int.
– volume: 133
  start-page: 2585
  year: 2013
  end-page: 2592
  ident: bib298
  article-title: Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis
  publication-title: J. Invest. Dermatol.
– volume: 39
  start-page: 7
  year: 2019
  ident: bib367
  article-title: LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
  publication-title: Biosci. Rep.
– volume: 12
  start-page: 13071
  year: 2020
  ident: bib141
  article-title: Long non-coding RNA LINC00466 knockdown inhibits tongue squamous cell carcinoma malignancy by targeting microRNA-493/HMGA2
  publication-title: Cancer Manag. Res.
– volume: 33
  start-page: 123
  year: 2020
  end-page: 130
  ident: bib50
  article-title: LncRNA SNHG8 promotes proliferation and invasion of gastric cancer cells by targeting the miR-491/PDGFRA axis
  publication-title: Hum. Cell
– volume: 29
  start-page: 1021
  year: 2020
  end-page: 1026
  ident: bib275
  article-title: Biomarker function of HMGA2 in ultraviolet‐induced skin cancer development
  publication-title: Exp. Dermatol.
– volume: 30
  start-page: 81
  year: 2019
  ident: bib333
  article-title: MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
  publication-title: Anti-Cancer Drugs
– volume: 12
  start-page: 7501
  year: 2019
  ident: bib170
  article-title: Long noncoding RNA ZFAS1 promotes progression of papillary thyroid carcinoma by sponging miR-590-3p and upregulating HMGA2 expression
  publication-title: OncoTargets Ther.
– volume: 23
  start-page: 23
  year: 2020
  end-page: 38
  ident: bib41
  article-title: IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2
  publication-title: Gastric Cancer
– volume: 35
  start-page: 720
  year: 2020
  end-page: 730
  ident: bib140
  article-title: Downregulation of lncRNA HOTTIP suppresses the proliferation, migration, and invasion of oral tongue squamous cell carcinoma by regulation of HMGA2-mediated Wnt/β-catenin pathway
  publication-title: Cancer Biotherapy Radiopharm.
– volume: 27
  start-page: 471
  year: 2019
  end-page: 476
  ident: bib164
  article-title: HMGA2 gene expression in fine-needle aspiration samples of thyroid nodules as a marker for preoperative diagnosis of thyroid cancer
  publication-title: Appl. Immunohistochem. Mol. Morphol.
– volume: 8
  year: 2017
  ident: bib51
  article-title: miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer
  publication-title: Cell Death Dis.
– volume: 31
  start-page: 209
  year: 2009
  end-page: 214
  ident: bib300
  article-title: Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features
  publication-title: J. Pediatr. Hematol. /Oncol.
– volume: 233
  start-page: 8630
  year: 2018
  end-page: 8638
  ident: bib65
  article-title: Long non‐coding RNA FEZF1–AS1 promotes breast cancer stemness and tumorigenesis via targeting miR‐30a/Nanog axis
  publication-title: J. Cell. Physiol.
– volume: 18
  start-page: 685
  year: 2020
  end-page: 697
  ident: bib81
  article-title: OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2OLR1–c-Myc–HMGA2 Promotes Metastasis in Pancreatic Cancer
  publication-title: Mol. Cancer Res.
– volume: 13
  start-page: 1
  year: 2013
  end-page: 8
  ident: bib87
  article-title: MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer
  publication-title: Cancer Cell Int.
– volume: 10
  start-page: 1
  year: 2019
  end-page: 15
  ident: bib114
  article-title: P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2
  publication-title: Cell Death Dis.
– volume: 12
  start-page: 24957
  year: 2020
  ident: bib294
  article-title: LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128
  publication-title: Aging (Albany NY)
– volume: 24
  start-page: 1
  year: 2019
  end-page: 11
  ident: bib330
  article-title: MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2
  publication-title: Cell. Mol. Biol. Lett.
– volume: 12
  start-page: 4749
  year: 2020
  ident: bib340
  article-title: MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level
  publication-title: Am. J. Transl. Res.
– volume: 117
  year: 2019
  ident: bib276
  article-title: MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma
  publication-title: Biomed. Pharmacother.
– volume: 8
  start-page: 1
  year: 2018
  end-page: 10
  ident: bib79
  article-title: Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
  publication-title: Sci. Rep.
– volume: 35
  year: 2021
  ident: bib290
  article-title: Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR‐497–5p/HMGA2 axis
  publication-title: J. Biochem. Mol. Toxicol.
– volume: 19
  start-page: 935
  year: 2019
  end-page: 942
  ident: bib147
  article-title: MicroRNA‑363–3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage
  publication-title: Mol. Med. Rep.
– volume: 37
  start-page: 699
  year: 2016
  end-page: 707
  ident: bib238
  article-title: Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer
  publication-title: Tumor Biol.
– volume: 12
  start-page: 525
  year: 2023
  ident: bib15
  article-title: Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis
  publication-title: Cells
– volume: 11
  start-page: 1482
  year: 2019
  ident: bib109
  article-title: An integrated bioinformatics analysis repurposes an antihelminthic drug niclosamide for treating HMGA2-overexpressing human colorectal cancer
  publication-title: Cancers
– volume: 7
  start-page: 2581
  year: 2018
  end-page: 2591
  ident: bib185
  article-title: miR‐541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high‐mobility group AT‐hook 2
  publication-title: Cancer Med.
– volume: 108
  start-page: 601
  year: 2020
  end-page: 613
  ident: bib354
  article-title: Layer‐by‐layer assembled PLGA nanoparticles carrying miR‐34a cargo inhibit the proliferation and cell cycle progression of triple‐negative breast cancer cells
  publication-title: J. Biomed. Mater. Res. Part A
– volume: 6
  start-page: 1
  year: 2016
  end-page: 9
  ident: bib251
  article-title: Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
  publication-title: Sci. Rep.
– volume: 49
  start-page: 1
  year: 2023
  end-page: 12
  ident: bib16
  article-title: MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer
  publication-title: Oncol. Rep.
– volume: 46
  start-page: 609
  year: 2020
  end-page: 620
  ident: bib329
  article-title: Exosomal microRNA‑146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2–mediated PI3K/Akt axis
  publication-title: Int. J. Mol. Med.
– volume: 7
  start-page: 260
  year: 2017
  ident: bib35
  article-title: HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation
  publication-title: Am. J. Cancer Res.
– volume: 12
  start-page: 835
  year: 2019
  ident: bib96
  article-title: miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6
  publication-title: OncoTargets Ther.
– volume: 6
  start-page: 57
  year: 2023
  ident: bib18
  article-title: Role of miR-944/MMP10/AXL-axis in lymph node metastasis in tongue cancer. Communications
  publication-title: Biology
– volume: 244
  start-page: 107
  year: 2018
  end-page: 119
  ident: bib44
  article-title: MicroRNA‐495–3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis
  publication-title: J. Pathol.
– volume: 120
  start-page: 11350
  year: 2019
  end-page: 11357
  ident: bib59
  article-title: Enhanced expression of circ_0000267 in hepatocellular carcinoma indicates poor prognosis and facilitates cell progression by sponging miR‐646
  publication-title: J. Cell. Biochem.
– volume: 932
  year: 2022
  ident: bib38
  article-title: Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
  publication-title: Eur. J. Pharmacol.
– volume: 13
  start-page: 714
  year: 2013
  end-page: 726
  ident: bib315
  article-title: Cancer drug resistance: an evolving paradigm
  publication-title: Nat. Rev. Cancer
– volume: 24
  start-page: 4710
  year: 2020
  end-page: 4718
  ident: bib240
  article-title: MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 81
  start-page: 431
  year: 2016
  end-page: 438
  ident: bib153
  article-title: miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2
  publication-title: Biomed. Pharmacother.
– volume: 10
  start-page: 177
  year: 2019
  end-page: 189
  ident: bib151
  article-title: Downregulation of miR-196-5p induced by hypoxia drives tumorigenesis and metastasis in hepatocellular carcinoma
  publication-title: Horm. Cancer
– volume: 36
  year: 2022
  ident: bib321
  article-title: SOX4 induces drug resistance of colorectal cancer cells by downregulating CYLD through transcriptional activation of microRNA‐17
  publication-title: J. Biochem. Mol. Toxicol.
– volume: 1
  start-page: 169
  year: 2012
  end-page: 174
  ident: bib125
  article-title: The roles of miRNA-143 in colon cancer and therapeutic implications. Transl Gastrointest
  publication-title: Cancer
– volume: 18
  start-page: 2524
  year: 2019
  end-page: 2537
  ident: bib159
  article-title: Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression
  publication-title: Cell Cycle
– volume: 22
  start-page: 6793
  year: 2018
  end-page: 6800
  ident: bib122
  article-title: Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 21
  start-page: 3610
  year: 2020
  ident: bib250
  article-title: Mir-370-3p impairs glioblastoma stem-like cell malignancy regulating a complex interplay between HMGA2/HIF1A and the oncogenic long non-coding RNA (lncRNA) NEAT1
  publication-title: Int. J. Mol. Sci.
– volume: 575
  start-page: 299
  year: 2019
  end-page: 309
  ident: bib312
  article-title: A view on drug resistance in cancer
  publication-title: Nature
– year: 2022
  ident: bib309
  article-title: LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR‐103a
  publication-title: J. Clin. Lab. Anal.
– volume: 37
  start-page: 168
  year: 2022
  end-page: 188
  ident: bib348
  article-title: Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy
  publication-title: J. Bioact. Compat. Polym.
– volume: 7
  start-page: 842
  year: 2018
  end-page: 855
  ident: bib209
  article-title: Lnc RNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA 2 axis in breast cancer
  publication-title: Cancer Med.
– volume: 24
  start-page: 112
  year: 2022
  ident: bib325
  article-title: miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells
  publication-title: Cell J. (Yakhteh)
– volume: 8
  start-page: 154
  year: 2022
  ident: bib23
  article-title: Tumor suppressive role of microRNA-4731-5p in breast cancer through reduction of PAICS-induced FAK phosphorylation
  publication-title: Cell Death Discov.
– volume: 34
  start-page: 364
  year: 2019
  end-page: 372
  ident: bib56
  article-title: miR-491 inhibits BGC-823 cell migration via targeting HMGA2
  publication-title: Int. J. Biol. Markers
– volume: 12
  start-page: 1
  year: 2021
  end-page: 13
  ident: bib108
  article-title: A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer
  publication-title: Cell Death Dis.
– volume: 21
  start-page: 1
  year: 2021
  end-page: 12
  ident: bib363
  article-title: CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis
  publication-title: Cancer Cell Int.
– volume: 86
  year: 2021
  ident: bib92
  article-title: Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway
  publication-title: Cell. Signal.
– volume: 20
  start-page: 1
  year: 2020
  end-page: 12
  ident: bib284
  article-title: Circular RNA circUBAP2 regulates proliferation and invasion of osteosarcoma cells through miR-641/YAP1 axis
  publication-title: Cancer Cell Int.
– start-page: 1
  year: 2022
  end-page: 13
  ident: bib336
  article-title: Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer
  publication-title: Br. J. Cancer
– volume: 121
  start-page: 2543
  year: 2020
  end-page: 2558
  ident: bib162
  article-title: SNHG16 as the miRNA let‐7b‐5p sponge facilitates the G2/M and epithelial‐mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma
  publication-title: J. Cell. Biochem.
– volume: 17
  start-page: 7451
  year: 2018
  end-page: 7459
  ident: bib308
  article-title: MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma
  publication-title: Mol. Med. Rep.
– volume: 5
  start-page: 1
  year: 2015
  end-page: 15
  ident: bib91
  article-title: Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
  publication-title: Sci. Rep.
– volume: 5
  start-page: 264
  year: 2013
  end-page: 279
  ident: bib194
  article-title: WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
  publication-title: EMBO Mol. Med.
– volume: 55
  start-page: 775
  year: 2019
  end-page: 788
  ident: bib32
  article-title: Oncological role of HMGA2
  publication-title: Int. J. Oncol.
– volume: 12
  start-page: 3537
  year: 2022
  ident: bib342
  article-title: miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma
  publication-title: Sci. Rep.
– volume: 8
  start-page: 21554
  year: 2017
  ident: bib226
  article-title: Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
  publication-title: Oncotarget
– volume: 9
  start-page: 7891
  year: 2018
  ident: bib231
  article-title: Increased high mobility group A 2 expression promotes transition of cervical intraepithelial neoplasm into cervical cancer
  publication-title: Oncotarget
– volume: 17
  start-page: 1149
  year: 2016
  end-page: 1157
  ident: bib120
  article-title: MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2
  publication-title: Cancer Biol. Ther.
– volume: 452
  start-page: 213
  year: 2019
  end-page: 225
  ident: bib197
  article-title: Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis
  publication-title: Cancer Lett.
– volume: 47
  start-page: 146
  year: 2014
  end-page: 151
  ident: bib216
  article-title: Expression of HMGA 2 in bladder cancer and its association with epithelial‐to‐mesenchymal transition
  publication-title: Cell Prolif.
– volume: 58
  start-page: 298
  year: 2021
  end-page: 311
  ident: bib286
  article-title: circUBAP2 regulates osteosarcoma progression via the miR‑204–3p/HMGA2 axis
  publication-title: Int. J. Oncol.
– volume: 377
  start-page: 55
  year: 2016
  end-page: 64
  ident: bib243
  article-title: The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma
  publication-title: Cancer Lett.
– volume: 73
  start-page: 705
  year: 2021
  end-page: 717
  ident: bib295
  article-title: The LINC01410/miR‐122–5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells
  publication-title: Iubmb Life
– volume: 40
  year: 2022
  ident: bib317
  article-title: Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer
  publication-title: Nanomed.: Nanotechnol., Biol. Med.
– volume: 66
  start-page: 4361
  year: 2021
  end-page: 4373
  ident: bib154
  article-title: Circular RNA circZFR promotes hepatocellular carcinoma progression by regulating miR-375/HMGA2 axis
  publication-title: Dig. Dis. Sci.
– volume: 171
  start-page: 389
  year: 2022
  end-page: 398
  ident: bib127
  article-title: Long non-coding RNA DANCR accelerates colorectal cancer progression via regulating the miR-185-5p/HMGA2 axis
  publication-title: J. Biochem.
– volume: 20
  start-page: 1
  year: 2020
  end-page: 12
  ident: bib187
  article-title: Circ_100565 promotes proliferation, migration and invasion in non-small cell lung cancer through upregulating HMGA2 via sponging miR-506-3p
  publication-title: Cancer Cell Int.
– volume: 40
  start-page: 436
  year: 2022
  end-page: 447
  ident: bib104
  article-title: LncRNA H19 promoted the epithelial to mesenchymal transition and metastasis in gastric cancer via activating Wnt/β-catenin signaling
  publication-title: Dig. Dis.
– volume: 14
  start-page: 1
  year: 2016
  end-page: 11
  ident: bib138
  article-title: Wu Y-l, Pan C-B. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway
  publication-title: J. Transl. Med.
– volume: 12
  start-page: 1197
  year: 2020
  ident: bib205
  article-title: Long non-coding RNA HOTAIR in breast cancer therapy
  publication-title: Cancers
– volume: 17
  start-page: 1330
  year: 2019
  end-page: 1336
  ident: bib57
  article-title: MicroRNA‑490–3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1
  publication-title: Exp. Ther. Med.
– volume: 5
  start-page: 563
  year: 2016
  end-page: 570
  ident: bib360
  article-title: MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2
  publication-title: Biol. Open
– start-page: 838
  year: 2002
  end-page: 844
  ident: bib29
  article-title: High-mobility-group chromosomal proteins, HMGA1 as potential tumour markers
  publication-title: Curr. Sci.
– volume: 22
  start-page: 1693
  year: 2018
  end-page: 1699
  ident: bib179
  article-title: Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 234
  start-page: 12809
  year: 2019
  end-page: 12820
  ident: bib306
  article-title: Long noncoding RNA HOXC13–AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR‐383–3p/HMGA2 axis
  publication-title: J. Cell. Physiol.
– volume: 16
  start-page: 1329
  year: 2022
  ident: bib323
  article-title: microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1
  publication-title: Mol. Oncol.
– volume: 13
  start-page: 1
  year: 2020
  end-page: 16
  ident: bib53
  article-title: Targeting the Wnt/β-catenin signaling pathway in cancer
  publication-title: J. Hematol. Oncol.
– volume: 6
  start-page: 249
  year: 2016
  ident: bib233
  article-title: Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis
  publication-title: Am. J. Cancer Res.
– volume: 13
  start-page: 2701
  year: 2020
  ident: bib157
  article-title: LINC02476 promotes the malignant phenotype of hepatocellular carcinoma by sponging miR-497 and increasing HMGA2 expression
  publication-title: OncoTargets Ther.
– volume: 11
  start-page: 2319
  year: 2018
  ident: bib198
  article-title: MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2
  publication-title: OncoTargets Ther.
– volume: 41
  start-page: 7
  year: 2021
  ident: bib260
  article-title: LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1
  publication-title: Biosci. Rep.
– volume: 93
  start-page: 1331
  year: 2013
  end-page: 1338
  ident: bib269
  article-title: Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis
  publication-title: Lab. Investig.
– volume: 39
  start-page: 9
  year: 2019
  ident: bib242
  article-title: Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer
  publication-title: Biosci. Rep.
– volume: 7
  start-page: 289
  year: 2014
  end-page: 292
  ident: bib225
  article-title: Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells
  publication-title: Asian Pac. J. Trop. Med.
– volume: 37
  start-page: 1
  year: 2018
  end-page: 17
  ident: bib234
  article-title: miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 10
  start-page: 525
  year: 2018
  ident: bib49
  article-title: MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer
  publication-title: Am. J. Transl. Res.
– volume: 43
  start-page: 1157
  year: 2019
  end-page: 1166
  ident: bib94
  article-title: lncRNA SNHG1 negatively regulates miRNA‑101–3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma
  publication-title: Int. J. Mol. Med.
– volume: 11
  start-page: 2207
  year: 2016
  end-page: 2212
  ident: bib291
  article-title: MicroRNA‑497 suppresses osteosarcoma tumor growth in vitro and in vivo
  publication-title: Oncol. Lett.
– volume: 12
  start-page: 10993
  year: 2020
  ident: bib235
  article-title: Circ_0109046 promotes the progression of endometrial cancer via regulating miR-136/HMGA2 axis
  publication-title: Cancer Manag. Res.
– volume: 44
  start-page: 2050
  year: 2014
  end-page: 2058
  ident: bib307
  article-title: MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2
  publication-title: Int. J. Oncol.
– volume: 12
  start-page: 1
  year: 2021
  end-page: 9
  ident: bib99
  article-title: Long non-coding RNA ZFAS1 promotes pancreatic cancer proliferation and metastasis by sponging miR-497-5p to regulate HMGA2 expression
  publication-title: Cell Death Dis.
– volume: 2
  start-page: 5
  year: 2014
  ident: bib3
  article-title: HMGA proteins as modulators of chromatin structure during transcriptional activation
  publication-title: Front. Cell Dev. Biol.
– volume: 504
  start-page: 196
  year: 2018
  end-page: 202
  ident: bib239
  article-title: High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 23
  start-page: 255
  year: 2017
  end-page: 264
  ident: bib137
  article-title: HMGA 2 is associated with the aggressiveness of tongue squamous cell carcinoma
  publication-title: Oral. Dis.
– volume: 7
  start-page: 3226
  year: 2018
  end-page: 3239
  ident: bib247
  article-title: HMGA 2 promotes glioma invasion and poor prognosis via a long‐range chromatin interaction
  publication-title: Cancer Med.
– volume: 13
  start-page: 1003
  year: 2023
  ident: bib19
  article-title: Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
  publication-title: Sci. Rep.
– volume: 24
  start-page: 2901
  year: 2020
  end-page: 2916
  ident: bib369
  article-title: Verbascoside inhibits progression of glioblastoma cells by promoting Let‐7g‐5p and down‐regulating HMGA2 via Wnt/beta‐catenin signalling blockade
  publication-title: J. Cell. Mol. Med.
– volume: 5
  start-page: 1353
  year: 2013
  end-page: 1356
  ident: bib144
  article-title: HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells
  publication-title: Oncol. Lett.
– volume: 105
  start-page: 346
  year: 2017
  end-page: 353
  ident: bib213
  article-title: The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer
  publication-title: Int. J. Biol. Macromol.
– volume: 24
  start-page: 905
  year: 2021
  end-page: 922
  ident: bib236
  article-title: lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway
  publication-title: Mol. Ther. -Nucleic Acids
– volume: 24
  start-page: 957
  year: 2018
  end-page: 966
  ident: bib266
  article-title: Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high‐grade glioma
  publication-title: CNS Neurosci. Ther.
– volume: 13
  start-page: 27
  year: 2020
  ident: bib281
  article-title: Inflammatory proteins HMGA2 and PRTN3 as drivers of vulvar squamous cell carcinoma progression
  publication-title: Cancers
– volume: 8
  start-page: 3656
  year: 2016
  ident: bib299
  article-title: Let-7a inhibits migration of melanoma cells via down-regulation of HMGA2 expression
  publication-title: Am. J. Transl. Res.
– volume: 9
  start-page: 9963
  year: 2018
  ident: bib112
  article-title: HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
  publication-title: Oncotarget
– volume: 192
  start-page: 353
  year: 2022
  end-page: 368
  ident: bib25
  article-title: Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression
  publication-title: Breast Cancer Res. Treat.
– volume: 8
  year: 2020
  ident: bib60
  article-title: Circ_0000267 promotes gastric cancer progression via sponging MiR‐503–5p and regulating HMGA2 expression
  publication-title: Mol. Genet. Genom. Med.
– year: 2023
  ident: bib52
  article-title: Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
  publication-title: Int. J. Biol. Macromol.
– volume: 24
  start-page: 4808
  year: 2018
  end-page: 4819
  ident: bib62
  article-title: LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 SignalingOncogenic Function of FEZF1-AS1 in Colorectal Cancer
  publication-title: Clin. Cancer Res.
– volume: 7
  start-page: 11271
  year: 2016
  ident: bib63
  article-title: Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma
  publication-title: Oncotarget
– volume: 13
  start-page: 8697
  year: 2021
  ident: bib155
  article-title: circNFIX facilitates hepatocellular carcinoma progression by targeting miR-3064-5p/HMGA2 to enhance glutaminolysis
  publication-title: Am. J. Transl. Res.
– volume: 10
  start-page: 3036
  year: 2018
  ident: bib230
  article-title: HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway
  publication-title: Am. J. Transl. Res.
– volume: 54
  start-page: 1290
  year: 2022
  end-page: 1305
  ident: bib24
  article-title: MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
  publication-title: Exp. Mol. Med.
– volume: 24
  start-page: 1824
  year: 2023
  ident: bib26
  article-title: MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF
  publication-title: Int. J. Mol. Sci.
– volume: 53
  start-page: 673
  year: 2021
  end-page: 682
  ident: bib221
  article-title: Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis
  publication-title: Acta Biochim. Et. Biophys. Sin.
– volume: 43
  start-page: 682
  year: 2022
  end-page: 692
  ident: bib27
  article-title: Exosomal microRNA-23b-3p promotes tumor angiogenesis and metastasis by targeting PTEN in salivary adenoid cystic carcinoma
  publication-title: Carcinogenesis
– volume: 40
  start-page: 219
  year: 2016
  end-page: 229
  ident: bib75
  article-title: The emerging roles of long noncoding RNA ROR (lincRNA-ROR) and its possible mechanisms in human cancers
  publication-title: Cell. Physiol. Biochem.
– volume: 7
  start-page: 44365
  year: 2016
  ident: bib246
  article-title: HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells
  publication-title: Oncotarget
– volume: 11
  start-page: 1427
  year: 2019
  ident: bib264
  article-title: FoxD2-AS1 promotes glioma progression by regulating miR-185–5 P/HMGA2 axis and PI3K/AKT signaling pathway
  publication-title: Aging (Albany NY)
– volume: 25
  start-page: 79
  year: 2019
  end-page: 88
  ident: bib301
  article-title: MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway
  publication-title: Cancer Biomark.
– volume: 21
  start-page: 1020
  year: 2017
  end-page: 1026
  ident: bib210
  article-title: lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 67
  start-page: 229
  year: 2020
  end-page: 237
  ident: bib89
  article-title: Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis
  publication-title: Acta Biochim. Pol.
– volume: 13
  start-page: 2501
  year: 2017
  end-page: 2506
  ident: bib146
  article-title: Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2–mediated Wnt/β‑catenin pathway
  publication-title: Exp. Ther. Med.
– volume: 9
  start-page: 6528
  year: 2021
  end-page: 6541
  ident: bib355
  article-title: Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer
  publication-title: Biomater. Sci.
– volume: 13
  start-page: 4411
  year: 2022
  end-page: 4427
  ident: bib287
  article-title: Circular RNA circ_UBAP2 facilitates the progression of osteosarcoma by regulating microRNA miR-637/high-mobility group box (HMGB) 2 axis
  publication-title: Bioengineered
– volume: 292
  start-page: 15395
  year: 2017
  end-page: 15407
  ident: bib161
  article-title: The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186
  publication-title: J. Biol. Chem.
– volume: 18
  start-page: 550
  year: 2019
  end-page: 558
  ident: bib339
  article-title: Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
  publication-title: Exp. Ther. Med.
– volume: 40
  start-page: 3654
  year: 2018
  end-page: 3662
  ident: bib45
  article-title: MicroRNA‑495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling
  publication-title: Oncol. Rep.
– volume: 39
  start-page: 9
  year: 2019
  ident: bib334
  article-title: MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression
  publication-title: Biosci. Rep.
– year: 2022
  ident: bib46
  article-title: Biological function and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and challenges
  publication-title: Pharmacol. Res.
– start-page: 2022
  year: 2022
  ident: bib101
  article-title: lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism
  publication-title: J. Immunol. Res.
– volume: 9
  start-page: 459
  year: 2006
  end-page: 471
  ident: bib33
  article-title: HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity
  publication-title: Cancer Cell
– volume: 65
  start-page: 1019
  year: 2020
  end-page: 1034
  ident: bib130
  article-title: RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: Oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation
  publication-title: J. Hum. Genet.
– volume: 1
  start-page: 1
  year: 2006
  end-page: 5
  ident: bib34
  article-title: E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression
  publication-title: Cell Div.
– volume: 37
  start-page: 1359
  year: 2017
  end-page: 1371
  ident: bib261
  article-title: MicroRNA-98 attenuates cell migration and invasion in glioma by directly targeting pre-B cell leukemia homeobox 3
  publication-title: Cell. Mol. Neurobiol.
– volume: 37
  start-page: 185
  year: 2017
  end-page: 192
  ident: bib39
  article-title: HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer
  publication-title: Oncol. Rep.
– volume: 9
  start-page: 18844
  year: 2019
  ident: bib332
  article-title: miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
  publication-title: Sci. Rep.
– volume: 19
  start-page: 267
  year: 2020
  end-page: 277
  ident: bib186
  article-title: Hydrophobically modified let-7b miRNA enhances biodistribution to NSCLC and downregulates HMGA2 in vivo
  publication-title: Mol. Ther. -Nucleic Acids
– volume: 96
  start-page: 1103
  year: 2017
  end-page: 1108
  ident: bib67
  article-title: Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway
  publication-title: Biomed. Pharmacother.
– volume: 47
  start-page: 56
  year: 2008
  end-page: 63
  ident: bib163
  article-title: Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias
  publication-title: Genes, Chromosomes Cancer
– reference: Zhang R., Zhang X., Zhang W., Cui W., Xiao Y., Liu L., et al. Sohlh2 regulates the stemness and differentiation of colon cancer stem cells by downregulating LncRNA-H19 transcription. Molecular Cancer Research, 2022.
– volume: 19
  start-page: 1463
  year: 2019
  end-page: 1470
  ident: bib184
  article-title: MiR‑495 suppresses cell proliferation by directly targeting HMGA2 in lung cancer
  publication-title: Mol. Med. Rep.
– volume: 376
  start-page: 284
  year: 2016
  end-page: 292
  ident: bib193
  article-title: Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer
  publication-title: Cancer Lett.
– volume: 499
  start-page: 75
  year: 2019
  end-page: 80
  ident: bib70
  article-title: Long noncoding RNA OIP5-AS1 in cancer
  publication-title: Clin. Chim. Acta
– volume: 33
  start-page: 448
  year: 2022
  end-page: 458
  ident: bib134
  article-title: Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis
  publication-title: Anti-Cancer Drugs
– volume: 11
  start-page: 1
  year: 2020
  end-page: 10
  ident: bib175
  article-title: HMGA2 regulates circular RNA ASPH to promote tumor growth in lung adenocarcinoma
  publication-title: Cell Death Dis.
– volume: 7
  start-page: 85058
  year: 2016
  ident: bib282
  article-title: Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva
  publication-title: Oncotarget
– volume: 5
  start-page: 1
  year: 2015
  end-page: 17
  ident: bib270
  article-title: Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma
  publication-title: Sci. Rep.
– volume: 23
  start-page: 1
  year: 2022
  end-page: 8
  ident: bib28
  article-title: MicroRNA‑20a promotes non‑small cell lung cancer proliferation by upregulating PD‑L1 by targeting PTEN
  publication-title: Oncol. Lett.
– volume: 14
  year: 2021
  ident: bib107
  article-title: Emerging roles for HMGA2 in colorectal cancer
  publication-title: Transl. Oncol.
– volume: 6
  start-page: 1769
  year: 2014
  end-page: 1792
  ident: bib313
  article-title: Drug resistance in cancer: an overview
  publication-title: Cancers
– volume: 14
  start-page: 5908
  year: 2022
  ident: bib86
  article-title: microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1
  publication-title: Aging (Albany NY)
– volume: 610
  start-page: 25
  year: 2016
  end-page: 32
  ident: bib200
  article-title: RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2
  publication-title: Arch. Biochem. Biophys.
– volume: 23
  start-page: 1
  year: 2021
  end-page: 10
  ident: bib214
  article-title: Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524–5p/HMGA2 axis
  publication-title: Mol. Med. Rep.
– volume: 38
  start-page: 5
  year: 2018
  ident: bib199
  article-title: microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2
  publication-title: Biosci. Rep.
– volume: 37
  start-page: 265
  year: 2011
  end-page: 271
  ident: bib217
  article-title: Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis: HMGA2 as a prognostic marker of bladder cancer
  publication-title: Eur. J. Surg. Oncol. (EJSO)
– volume: 3
  start-page: 1439
  year: 2012
  ident: bib257
  article-title: Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity
  publication-title: Oncotarget
– volume: 16
  start-page: 3557
  year: 2017
  end-page: 3564
  ident: bib180
  article-title: MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2
  publication-title: Mol. Med. Rep.
– year: 2022
  ident: bib11
  article-title: Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives
  publication-title: Pharmacol. Res.
– volume: 9
  start-page: 2
  year: 2021
  ident: bib305
  article-title: Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma
  publication-title: Ann. Transl. Med.
– volume: 1511
  start-page: 107
  year: 2022
  end-page: 118
  ident: bib263
  article-title: CircABCC1 promotes the development of glioma by sponging miR‐591 and modulating high‐mobility group A2
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 28
  start-page: 203
  year: 2020
  ident: bib93
  article-title: MiRNA-101 targets TGF-βR1 to retard the progression of oral squamous cell carcinoma
  publication-title: Oncol. Res.
– volume: 8
  start-page: 61687
  year: 2017
  ident: bib285
  article-title: Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression
  publication-title: Oncotarget
– volume: 23
  year: 2017
  ident: bib78
  article-title: Long non-coding RNA reprogramming (ROR) promotes cell proliferation in colorectal cancer via affecting P53
  publication-title: Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res.
– volume: 13
  start-page: 5197
  year: 2021
  ident: bib191
  article-title: HMGA2 supports cancer hallmarks in triple-negative breast cancer
  publication-title: Cancers
– volume: 6
  start-page: 743
  year: 2008
  end-page: 750
  ident: bib173
  article-title: HMGA2 participates in transformation in human lung cancer
  publication-title: Mol. Cancer Res.
– volume: 418
  year: 2022
  ident: bib271
  article-title: HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma
  publication-title: Exp. Cell Res.
– volume: 19
  year: 2020
  ident: bib84
  article-title: MiR-590 suppresses proliferation and induces apoptosis in pancreatic cancer by targeting high mobility group A2
  publication-title: Technol. Cancer Res. Treat.
– volume: 11
  start-page: 4075
  year: 2019
  ident: bib82
  article-title: Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer
  publication-title: Cancer Manag. Res.
– volume: 24
  start-page: 122
  year: 2020
  end-page: 129
  ident: bib85
  article-title: MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 10
  start-page: 1151
  year: 2020
  ident: bib352
  article-title: Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer
  publication-title: Theranostics
– volume: 20
  start-page: 1080
  year: 2021
  end-page: 1090
  ident: bib359
  article-title: HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis
  publication-title: Cell Cycle
– volume: 51
  year: 2021
  ident: bib133
  article-title: High‐mobility group AT‐hook 2 promotes growth and metastasis and is regulated by miR‐204–5p in oesophageal squamous cell carcinoma
  publication-title: Eur. J. Clin. Investig.
– volume: 38
  start-page: 7399
  year: 2019
  end-page: 7415
  ident: bib256
  article-title: An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme
  publication-title: Oncogene
– volume: 40
  start-page: 6
  year: 2020
  ident: bib277
  article-title: Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma
  publication-title: Biosci. Rep.
– volume: 6
  start-page: 684
  year: 2014
  end-page: 697
  ident: bib6
  article-title: Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cells
  publication-title: Cell Rep.
– year: 2021
  ident: bib55
  article-title: Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: prospects for the therapeutic management of breast cancer
  publication-title: Seminars in cancer biology
– volume: 158
  start-page: 224
  year: 2019
  end-page: 232
  ident: bib288
  article-title: MiR-204-5p promotes apoptosis and inhibits migration of osteosarcoma via targeting EBF2
  publication-title: Biochimie
– volume: 80
  year: 2020
  ident: bib232
  article-title: Ectopic expression of miR-142-3p suppresses growth, migration, colony formation and induces apoptosis by down-regulating HMGA1, HMGA2, HMGB1 and HMGB3 in human cervical cancer cells
  publication-title: Cancer Res.
– volume: 11
  start-page: 2332
  year: 2022
  ident: bib343
  article-title: MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
  publication-title: Cells
– volume: 13
  start-page: 12829
  year: 2020
  ident: bib160
  article-title: Tumor-linked macrophages promote HCC development by mediating the CCAT1/Let-7b/HMGA2 signaling pathway
  publication-title: OncoTargets Ther.
– volume: 59
  start-page: 1648
  year: 2021
  end-page: 1665
  ident: bib202
  article-title: CircARL8B Contributes to the Development of Breast Cancer Via Regulating miR-653-5p/HMGA2 Axis
  publication-title: Biochem. Genet.
– volume: 126
  start-page: 503
  year: 2006
  end-page: 514
  ident: bib5
  article-title: A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation
  publication-title: Cell
– start-page: 11
  year: 2021
  ident: bib229
  article-title: ER-α36 promotes the malignant progression of cervical cancer mediated by estrogen via HMGA2
  publication-title: Front. Oncol.
– volume: 20
  start-page: 2473
  year: 2019
  ident: bib268
  article-title: HMGA2 contributes to distant metastasis and poor prognosis by promoting angiogenesis in oral squamous cell carcinoma
  publication-title: Int. J. Mol. Sci.
– volume: 110
  start-page: 9920
  year: 2013
  end-page: 9925
  ident: bib195
  article-title: HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
  publication-title: Proc. Natl. Acad. Sci.
– volume: 7
  start-page: 25872
  year: 2016
  ident: bib272
  article-title: HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
  publication-title: Oncotarget
– volume: 52
  start-page: 183
  year: 2020
  end-page: 191
  ident: bib54
  article-title: Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
  publication-title: Exp. Mol. Med.
– volume: 17
  start-page: 2712
  year: 2018
  end-page: 2718
  ident: bib181
  article-title: microRNA-363-3p inhibits cell growth and invasion of non‑small cell lung cancer by targeting HMGA2
  publication-title: Mol. Med. Rep.
– volume: 10
  start-page: 94
  year: 1994
  end-page: 100
  ident: bib30
  article-title: HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
  publication-title: Trends Genet.
– volume: 36
  start-page: 2051
  year: 2015
  end-page: 2062
  ident: bib293
  article-title: The down-regulation of microRNA-497 contributes to cell growth and cisplatin resistance through PI3K/Akt pathway in osteosarcoma
  publication-title: Cell. Physiol. Biochem.
– volume: 65
  start-page: 118
  year: 2019
  end-page: 122
  ident: bib95
  article-title: MicroRNA-101-3p regulates gastric cancer cell proliferation, invasion and apoptosis by targeting PIM 1 expression
  publication-title: Cell. Mol. Biol.
– volume: 20
  start-page: 1337
  year: 2021
  end-page: 1343
  ident: bib123
  article-title: MiR-143-5p inhibits proliferation, invasion, and epithelial to mesenchymal transition of colorectal cancer cells by downregulation of HMGA2
  publication-title: Trop. J. Pharm. Res.
– volume: 35
  start-page: 350
  year: 2017
  end-page: 360
  ident: bib14
  article-title: Nanocarriers for microRNA delivery in cancer medicine
  publication-title: Biotechnol. Adv.
– start-page: 1
  year: 2022
  end-page: 15
  ident: bib322
  article-title: microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells
  publication-title: Cell Biol. Toxicol.
– volume: 7
  start-page: 862
  year: 2016
  ident: bib274
  article-title: ANG promotes proliferation and invasion of the cell of lung squamous carcinoma by directly up-regulating HMGA2
  publication-title: J. Cancer
– volume: 852
  start-page: 42
  year: 2019
  end-page: 50
  ident: bib368
  article-title: MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2
  publication-title: Eur. J. Pharmacol.
– volume: 53
  start-page: 815
  year: 2021
  end-page: 822
  ident: bib241
  article-title: hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis
  publication-title: Acta Biochim. Et. Biophys. Sin.
– volume: 349
  start-page: 712
  year: 2022
  end-page: 730
  ident: bib249
  article-title: MicroRNA delivery systems in glioma therapy and perspectives: A systematic review
  publication-title: J. Control. Release
– volume: 30
  year: 2022
  ident: bib206
  article-title: LncRNA HOTAIR promotes the proliferation and invasion/metastasis of breast cancer cells by targeting the miR-130a-3p/Suv39H1 axis
  publication-title: Biochem. Biophys. Rep.
– volume: 18
  start-page: 2317
  year: 2017
  ident: bib207
  article-title: The long noncoding RNA HOTAIR in breast cancer: does autophagy play a role?
  publication-title: Int. J. Mol. Sci.
– volume: 40
  start-page: 1
  year: 2021
  end-page: 24
  ident: bib58
  article-title: CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 9
  start-page: 3
  year: 2023
  ident: bib20
  article-title: Mesenchymal stem cell-derived extracellular vesicles transfer miR-598 to inhibit the growth and metastasis of non-small-cell lung cancer by targeting THBS2
  publication-title: Cell Death Discov.
– volume: 22
  start-page: 424
  year: 2017
  end-page: 432
  ident: bib13
  article-title: miRNA nanotherapeutics for cancer
  publication-title: Drug Discov. Today
– volume: 22
  start-page: e286
  year: 2022
  end-page: e295
  ident: bib201
  article-title: Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2
  publication-title: Clin. Breast Cancer
– volume: 2
  start-page: 141
  year: 2019
  ident: bib314
  article-title: Drug resistance and combating drug resistance in cancer
  publication-title: Cancer Drug Resist.
– volume: 10
  start-page: 129
  year: 2017
  ident: bib42
  article-title: Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker
  publication-title: OncoTargets Ther.
– volume: 15
  year: 2021
  ident: bib341
  article-title: MicroRNA-19b downregulates NR3C1 and enhances oxaliplatin chemoresistance in colon cancer via the PI3K/AKT/mTOR pathway
  publication-title: Clin. Med. Insight.: Oncol.
– year: 2022
  ident: bib10
  article-title: Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
  publication-title: Int. J. Biol. Macromol.
– volume: 23
  start-page: 640
  year: 2017
  ident: bib48
  article-title: MicroRNA-495 inhibits gastric cancer cell migration and invasion possibly via targeting high mobility group AT-hook 2 (HMGA2)
  publication-title: Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res.
– volume: 35
  start-page: 1529
  year: 2016
  end-page: 1540
  ident: bib192
  article-title: Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2
  publication-title: Oncogene
– volume: 6
  start-page: 9257
  year: 2015
  ident: bib255
  article-title: miR-340 suppresses glioblastoma multiforme
  publication-title: Oncotarget
– volume: 14
  start-page: 2021
  year: 2022
  ident: bib326
  article-title: MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1
  publication-title: Am. J. Transl. Res.
– volume: 505
  start-page: 212
  year: 2014
  end-page: 217
  ident: bib176
  article-title: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
  publication-title: Nature
– volume: 27
  year: 2020
  ident: bib76
  article-title: lncRNA ROR promotes gastric cancer drug resistance
  publication-title: Cancer Control
– volume: 9
  start-page: 8927
  year: 2018
  ident: bib278
  article-title: Let-7c inhibits migration and epithelial–mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2
  publication-title: Oncotarget
– volume: 10
  start-page: 1
  year: 2019
  end-page: 10
  ident: bib212
  article-title: Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
  publication-title: Cell Death Dis.
– volume: 118
  start-page: 449
  year: 2017
  end-page: 452
  ident: bib292
  article-title: MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway
  publication-title: Bratisl. Lek. Listy
– volume: 22
  start-page: 8353
  year: 2018
  end-page: 8366
  ident: bib177
  article-title: The role of let-7 and HMGA2 in the occurrence and development of lung cancer: a systematic review and meta-analysis
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 11
  start-page: 10859
  year: 2019
  ident: bib204
  article-title: Long intergenic non-coding RNA 01121 promotes breast cancer cell proliferation, migration, and invasion via the miR-150-5p/HMGA2 axis
  publication-title: Cancer Manag. Res.
– volume: 39
  year: 2017
  ident: bib167
  article-title: Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2
  publication-title: Tumor Biol.
– volume: 17
  start-page: 515
  year: 2016
  end-page: 525
  ident: bib365
  article-title: Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer
  publication-title: Cancer Biol. Ther.
– volume: 155
  year: 2022
  ident: bib36
  article-title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
  publication-title: Biomed. Pharmacother.
– volume: 21
  start-page: 1025
  year: 2007
  end-page: 1030
  ident: bib178
  article-title: The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
  publication-title: Genes Dev.
– volume: 154
  year: 2022
  ident: bib8
  article-title: LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
  publication-title: Biomed. Pharmacother.
– reference: Meyer B., Loeschke S., Schultze A., Weigel T., Sandkamp M., Goldmann T., et al. HMGA2 overexpression in non‐small cell lung cancer. Molecular Carcinogenesis: Published in cooperation with the University of Texas MD Anderson Cancer Center, 2007;46(7):503–11.
– volume: 8
  start-page: 169
  year: 2015
  ident: bib302
  article-title: HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
  publication-title: OncoTargets Ther.
– volume: 38
  start-page: 14
  year: 1973
  end-page: 19
  ident: bib2
  article-title: A new group of chromatin‐associated proteins with a high content of acidic and basic amino acids
  publication-title: Eur. J. Biochem.
– volume: 43
  start-page: 840
  year: 2017
  end-page: 851
  ident: bib102
  article-title: CXCR4/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2
  publication-title: Cell. Physiol. Biochem.
– year: 2021
  ident: bib248
  article-title: Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma
  publication-title: Seminars in Cancer Biology
– start-page: 1
  year: 2023
  end-page: 10
  ident: bib21
  article-title: MicroRNA-10a-5p targets SERPINE1 to suppress cell progression and epithelial–mesenchymal transition process in clear cell renal cell carcinoma
  publication-title: Mol. Cell. Toxicol.
– volume: 12
  start-page: 1852
  year: 2020
  ident: bib12
  article-title: A comprehensive review of cancer MicroRNA therapeutic delivery strategies
  publication-title: Cancers
– volume: 120
  start-page: 7499
  issue: 5
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib71
  article-title: LncRNA OIP5–AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.28024
– volume: 13
  start-page: 27
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib281
  article-title: Inflammatory proteins HMGA2 and PRTN3 as drivers of vulvar squamous cell carcinoma progression
  publication-title: Cancers
  doi: 10.3390/cancers13010027
– start-page: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib322
  article-title: microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells
  publication-title: Cell Biol. Toxicol.
– volume: 21
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib357
  article-title: Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
  publication-title: BMC Cancer
  doi: 10.1186/s12885-021-09020-y
– start-page: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib366
  article-title: miR-219-5p attenuates cisplatin resistance of ovarian cancer by inactivating Wnt/β-catenin signaling and autophagy via targeting HMGA2
  publication-title: Cancer Gene Ther.
– volume: 40
  start-page: 3654
  issue: 6
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib45
  article-title: MicroRNA‑495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling
  publication-title: Oncol. Rep.
– volume: 38
  start-page: 5
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib199
  article-title: microRNA-98 inhibits the proliferation, invasion, migration and promotes apoptosis of breast cancer cells by binding to HMGA2
  publication-title: Biosci. Rep.
– volume: 7
  start-page: 2581
  issue: 6
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib185
  article-title: miR‐541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high‐mobility group AT‐hook 2
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1491
– volume: 84
  start-page: 427
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib331
  article-title: MicroRNA-552 deficiency mediates 5-fluorouracil resistance by targeting SMAD2 signaling in DNA-mismatch-repair-deficient colorectal cancer
  publication-title: Cancer Chemother. Pharmacol.
  doi: 10.1007/s00280-019-03866-7
– volume: 16
  start-page: 1329
  issue: 6
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib323
  article-title: microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1
  publication-title: Mol. Oncol.
  doi: 10.1002/1878-0261.13192
– year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib52
  article-title: Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2023.123377
– year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib37
  article-title: Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2022.106535
– volume: 58
  start-page: 298
  issue: 3
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib286
  article-title: circUBAP2 regulates osteosarcoma progression via the miR‑204–3p/HMGA2 axis
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2021.5178
– volume: 12
  start-page: 4749
  issue: 8
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib340
  article-title: MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level
  publication-title: Am. J. Transl. Res.
– volume: 184
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib103
  article-title: Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2022.106418
– volume: 52
  start-page: 183
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib54
  article-title: Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-020-0380-6
– volume: 505
  start-page: 212
  issue: 7482
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib176
  article-title: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
  publication-title: Nature
  doi: 10.1038/nature12785
– volume: 8
  start-page: 154
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib23
  article-title: Tumor suppressive role of microRNA-4731-5p in breast cancer through reduction of PAICS-induced FAK phosphorylation
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-022-00938-1
– volume: 41
  start-page: 229
  issue: 2
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib237
  article-title: Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells
  publication-title: J. Biosci.
  doi: 10.1007/s12038-016-9603-3
– volume: 1511
  start-page: 107
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib263
  article-title: CircABCC1 promotes the development of glioma by sponging miR‐591 and modulating high‐mobility group A2
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.14717
– volume: 28
  start-page: 51
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib66
  article-title: The lncRNA FEZF1-AS1 promotes the progression of colorectal cancer through regulating OTX1 and targeting miR-30a-5p
  publication-title: Oncol. Res.
  doi: 10.3727/096504019X15619783964700
– volume: 27
  start-page: 1
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib318
  article-title: The role of epigenetic modifications in drug resistance and treatment of breast cancer
  publication-title: Cell. Mol. Biol. Lett.
  doi: 10.1186/s11658-022-00344-6
– volume: 11
  start-page: 5666
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib338
  article-title: MicroRNA-155-5p contributes to 5-fluorouracil resistance through down-regulating TP53INP1 in oral squamous cell carcinoma
  publication-title: Front. Oncol.
– volume: 22
  start-page: 6793
  issue: 20
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib122
  article-title: Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 64
  start-page: 496
  issue: 5
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib262
  article-title: MicroRNA-98 promotes cell proliferation and invasion of glioblastoma via targeting HMGA2
  publication-title: J. Neurosurg. Sci.
  doi: 10.23736/S0390-5616.19.04792-1
– volume: 497
  start-page: 20
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib61
  article-title: Long noncoding RNA FEZF1-AS1 in human cancers
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2019.07.004
– volume: 81
  start-page: 431
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib153
  article-title: miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2016.04.034
– volume: 39
  start-page: 9
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib334
  article-title: MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20190421
– volume: 53
  start-page: 815
  issue: 7
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib241
  article-title: hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/HMGA2 axis
  publication-title: Acta Biochim. Et. Biophys. Sin.
  doi: 10.1093/abbs/gmab058
– volume: 20
  start-page: 1
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib100
  article-title: LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01322-8
– volume: 12
  start-page: 7501
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib170
  article-title: Long noncoding RNA ZFAS1 promotes progression of papillary thyroid carcinoma by sponging miR-590-3p and upregulating HMGA2 expression
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S209138
– volume: 35
  start-page: 350
  issue: 3
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib14
  article-title: Nanocarriers for microRNA delivery in cancer medicine
  publication-title: Biotechnol. Adv.
  doi: 10.1016/j.biotechadv.2017.03.002
– volume: 7
  start-page: 85058
  issue: 51
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib282
  article-title: Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.13187
– volume: 418
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib271
  article-title: HMGA2-Snai2 axis regulates tumorigenicity and stemness of head and neck squamous cell carcinoma
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2022.113271
– volume: 13
  start-page: 4411
  issue: 2
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib287
  article-title: Circular RNA circ_UBAP2 facilitates the progression of osteosarcoma by regulating microRNA miR-637/high-mobility group box (HMGB) 2 axis
  publication-title: Bioengineered
  doi: 10.1080/21655979.2022.2033447
– volume: 13
  start-page: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib53
  article-title: Targeting the Wnt/β-catenin signaling pathway in cancer
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-020-00990-3
– volume: 17
  start-page: 2712
  issue: 2
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib181
  article-title: microRNA-363-3p inhibits cell growth and invasion of non‑small cell lung cancer by targeting HMGA2
  publication-title: Mol. Med. Rep.
– volume: 110
  start-page: 9920
  issue: 24
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib195
  article-title: HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.1305172110
– start-page: 2022
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib101
  article-title: lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism
  publication-title: J. Immunol. Res.
– volume: 1799
  start-page: 3
  issue: 1–2
  year: 2010
  ident: 10.1016/j.phrs.2023.106732_bib4
  article-title: Nuclear functions of the HMG proteins
  publication-title: Biochim. Et. Biophys. Acta (BBA)-Gene Regul. Mech.
  doi: 10.1016/j.bbagrm.2009.09.001
– volume: 8
  start-page: 3656
  issue: 9
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib299
  article-title: Let-7a inhibits migration of melanoma cells via down-regulation of HMGA2 expression
  publication-title: Am. J. Transl. Res.
– volume: 105
  start-page: 346
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib213
  article-title: The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2017.07.053
– volume: 10
  start-page: 1
  issue: 4
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib212
  article-title: Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-019-1513-5
– volume: 185
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib9
  article-title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2022.106475
– volume: 7
  start-page: 3889
  issue: 16
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib119
  article-title: Overexpression of miR-194 reverses HMGA2-driven signatures in colorectal cancer
  publication-title: Theranostics
  doi: 10.7150/thno.20041
– volume: 120
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib156
  article-title: LINC00473 promotes hepatocellular carcinoma progression via acting as a ceRNA for microRNA-195 and increasing HMGA2 expression
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2019.109403
– volume: 59
  start-page: 467
  issue: 5
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib174
  article-title: PP4R1 interacts with HMGA2 to promote non‐small‐cell lung cancer migration and metastasis via activating MAPK/ERK‐induced epithelial‐mesenchymal transition
  publication-title: Mol. Carcinog.
  doi: 10.1002/mc.23168
– year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib248
  article-title: Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma
– volume: 40
  start-page: 436
  issue: 4
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib104
  article-title: LncRNA H19 promoted the epithelial to mesenchymal transition and metastasis in gastric cancer via activating Wnt/β-catenin signaling
  publication-title: Dig. Dis.
  doi: 10.1159/000518627
– volume: 11
  start-page: 10859
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib204
  article-title: Long intergenic non-coding RNA 01121 promotes breast cancer cell proliferation, migration, and invasion via the miR-150-5p/HMGA2 axis
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S230367
– volume: 37
  start-page: 1891
  issue: 4
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib273
  article-title: High HMGA2 expression correlates with reduced recurrence-free survival and poor overall survival in oral squamous cell carcinoma
  publication-title: Anticancer Res.
  doi: 10.21873/anticanres.11527
– volume: 8
  start-page: 61687
  issue: 37
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib285
  article-title: Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.18671
– volume: 852
  start-page: 42
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib368
  article-title: MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2019.03.005
– volume: 80
  start-page: 29
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib196
  article-title: Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer
  publication-title: Matrix Biol.
  doi: 10.1016/j.matbio.2018.09.002
– volume: 54
  start-page: 35
  year: 1996
  ident: 10.1016/j.phrs.2023.106732_bib1
  article-title: High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function
  publication-title: Prog. Nucleic Acid. Res. Mol. Biol.
  doi: 10.1016/S0079-6603(08)60360-8
– volume: 234
  start-page: 21359
  issue: 11
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib124
  article-title: miRNA‐143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.28745
– volume: 12
  start-page: 3013
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib152
  article-title: Effect and mechanism of miR-26a-5p on proliferation and apoptosis of hepatocellular carcinoma cells
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S237752
– volume: 9
  start-page: 18844
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib332
  article-title: miR-200 affects tamoxifen resistance in breast cancer cells through regulation of MYB
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-54289-6
– volume: 54
  start-page: 1290
  issue: 8
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib24
  article-title: MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-022-00837-6
– volume: 24
  start-page: 4808
  issue: 19
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib62
  article-title: LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 SignalingOncogenic Function of FEZF1-AS1 in Colorectal Cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-17-2967
– volume: 11
  start-page: 4075
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib82
  article-title: Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S199289
– volume: 37
  start-page: 7515
  issue: 6
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib215
  article-title: Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial–mesenchymal transition in bladder cancer
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-015-4625-2
– volume: 7
  start-page: 44365
  issue: 28
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib246
  article-title: HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9744
– volume: 6
  start-page: 9257
  issue: 11
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib255
  article-title: miR-340 suppresses glioblastoma multiforme
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3288
– volume: 27
  start-page: 1
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib320
  article-title: CRISPR/Cas9 gene editing: A new approach for overcoming drug resistance in cancer
  publication-title: Cell. Mol. Biol. Lett.
  doi: 10.1186/s11658-022-00348-2
– volume: 35
  issue: 12
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib290
  article-title: Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR‐497–5p/HMGA2 axis
  publication-title: J. Biochem. Mol. Toxicol.
  doi: 10.1002/jbt.22921
– volume: 6
  start-page: 684
  issue: 4
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib6
  article-title: Chaperoning HMGA2 protein protects stalled replication forks in stem and cancer cells
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.01.014
– volume: 13
  start-page: 1
  issue: 1
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib87
  article-title: MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer
  publication-title: Cancer Cell Int.
  doi: 10.1186/1475-2867-13-95
– volume: 23
  start-page: 640
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib48
  article-title: MicroRNA-495 inhibits gastric cancer cell migration and invasion possibly via targeting high mobility group AT-hook 2 (HMGA2)
  publication-title: Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res.
  doi: 10.12659/MSM.898740
– volume: 41
  issue: 2
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib126
  article-title: Circular RNA 100146 promotes colorectal cancer progression by the MicroRNA 149/HMGA2 Axis
  publication-title: Mol. Cell. Biol.
  doi: 10.1128/MCB.00445-20
– volume: 16
  start-page: 432
  issue: 4
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib98
  article-title: miRNA-101 suppresses epithelial-to-mesenchymal transition by targeting HMGA2 in pancreatic cancer cells
  publication-title: Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. -Anti-Cancer Agents)
– volume: 20
  start-page: 1337
  issue: 7
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib123
  article-title: MiR-143-5p inhibits proliferation, invasion, and epithelial to mesenchymal transition of colorectal cancer cells by downregulation of HMGA2
  publication-title: Trop. J. Pharm. Res.
  doi: 10.4314/tjpr.v20i7.3
– volume: 27
  start-page: 173
  issue: 2
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib143
  article-title: H19 facilitates tongue squamous cell carcinoma migration and invasion via sponging miR-let-7
  publication-title: Oncol. Res.
  doi: 10.3727/096504018X15202945197589
– volume: 47
  start-page: 56
  issue: 1
  year: 2008
  ident: 10.1016/j.phrs.2023.106732_bib163
  article-title: Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias
  publication-title: Genes, Chromosomes Cancer
  doi: 10.1002/gcc.20505
– volume: 34
  start-page: 364
  issue: 4
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib56
  article-title: miR-491 inhibits BGC-823 cell migration via targeting HMGA2
  publication-title: Int. J. Biol. Markers
  doi: 10.1177/1724600819874488
– volume: 8
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib60
  article-title: Circ_0000267 promotes gastric cancer progression via sponging MiR‐503–5p and regulating HMGA2 expression
  publication-title: Mol. Genet. Genom. Med.
– volume: 393
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib83
  article-title: High mobility group AT-hook 2 promotes tumorigenicity of pancreatic cancer cells via upregulating ANLN
  publication-title: Exp. Cell Res.
  doi: 10.1016/j.yexcr.2020.112088
– volume: 6
  start-page: 743
  issue: 5
  year: 2008
  ident: 10.1016/j.phrs.2023.106732_bib173
  article-title: HMGA2 participates in transformation in human lung cancer
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-07-0095
– volume: 21
  start-page: 1
  issue: 3
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib361
  article-title: MicroRNA‑9–5p increases the sensitivity of colorectal cancer cells to 5–fluorouracil by downregulating high mobility group A2 expression
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2021.12496
– volume: 11
  start-page: 2319
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib198
  article-title: MicroRNA-150 suppresses triple-negative breast cancer metastasis through targeting HMGA2
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S161996
– ident: 10.1016/j.phrs.2023.106732_bib279
  doi: 10.1111/odi.14399
– volume: 13
  start-page: 10489
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib110
  article-title: TAGLN and High-mobility Group AT-Hook 2 (HMGA2) complex regulates TGF-β-induced colorectal cancer metastasis
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S263090
– volume: 17
  start-page: 515
  issue: 5
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib365
  article-title: Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer
  publication-title: Cancer Biol. Ther.
  doi: 10.1080/15384047.2015.1095405
– volume: 12
  start-page: 13071
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib141
  article-title: Long non-coding RNA LINC00466 knockdown inhibits tongue squamous cell carcinoma malignancy by targeting microRNA-493/HMGA2
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S282625
– volume: 11
  start-page: 14647
  issue: 16
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib351
  article-title: ROS-responsive polymeric micelles for triggered simultaneous delivery of PLK1 inhibitor/miR-34a and effective synergistic therapy in pancreatic cancer
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.9b02756
– volume: 67
  start-page: 229
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib89
  article-title: Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis
  publication-title: Acta Biochim. Pol.
– volume: 29
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib68
  article-title: LncRNA FEZF1-AS1 modulates cancer stem cell properties of human gastric cancer through miR-363-3p/HMGA2
  publication-title: Cell Transplant.
  doi: 10.1177/0963689720925059
– volume: 9
  start-page: 9963
  issue: 11
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib112
  article-title: HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24133
– volume: 19
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib84
  article-title: MiR-590 suppresses proliferation and induces apoptosis in pancreatic cancer by targeting high mobility group A2
  publication-title: Technol. Cancer Res. Treat.
– volume: 21
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib363
  article-title: CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-021-02088-3
– volume: 14
  start-page: 2021
  issue: 3
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib326
  article-title: MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1
  publication-title: Am. J. Transl. Res.
– volume: 13
  start-page: 8697
  issue: 8
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib155
  article-title: circNFIX facilitates hepatocellular carcinoma progression by targeting miR-3064-5p/HMGA2 to enhance glutaminolysis
  publication-title: Am. J. Transl. Res.
– volume: 14
  start-page: 1
  issue: 1
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib138
  article-title: Wu Y-l, Pan C-B. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-016-0777-0
– volume: 53
  start-page: 673
  issue: 6
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib221
  article-title: Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis
  publication-title: Acta Biochim. Et. Biophys. Sin.
  doi: 10.1093/abbs/gmab041
– volume: 9
  start-page: 7891
  issue: 8
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib231
  article-title: Increased high mobility group A 2 expression promotes transition of cervical intraepithelial neoplasm into cervical cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24080
– volume: 52
  start-page: 773
  issue: 7
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib73
  article-title: Long non-coding RNA OIP5-AS1 promotes the growth of gastric cancer through the miR-367-3p/HMGA2 axis
  publication-title: Dig. Liver Dis.
  doi: 10.1016/j.dld.2019.11.017
– volume: 28
  start-page: 2467
  issue: 14
  year: 2010
  ident: 10.1016/j.phrs.2023.106732_bib244
  article-title: Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.26.6213
– volume: 24
  start-page: 8812
  issue: 17
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib115
  article-title: MiR-543 inhibits proliferation and metastasis of human colorectal cancer cells by targeting PLAS3
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 120
  start-page: 11350
  issue: 7
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib59
  article-title: Enhanced expression of circ_0000267 in hepatocellular carcinoma indicates poor prognosis and facilitates cell progression by sponging miR‐646
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.28411
– volume: 12
  start-page: 11623
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib158
  article-title: Long non-coding RNA EGOT promotes the malignant phenotypes of hepatocellular carcinoma cells and increases the expression of HMGA2 via down-regulating miR-33a-5p
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S218308
– volume: 121
  start-page: 3814
  issue: 8–9
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib190
  article-title: Knockdown of lncRNA ZFAS1–suppressed non–small cell lung cancer progression via targeting the miR‐150–5p/HMGA2 signaling
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.29542
– volume: 10
  start-page: 3036
  issue: 10
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib230
  article-title: HMGA2 gene silencing reduces epithelial-mesenchymal transition and lymph node metastasis in cervical cancer through inhibiting the ATR/Chk1 signaling pathway
  publication-title: Am. J. Transl. Res.
– volume: 73
  start-page: 705
  issue: 4
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib295
  article-title: The LINC01410/miR‐122–5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells
  publication-title: Iubmb Life
  doi: 10.1002/iub.2452
– volume: 6
  start-page: 1769
  issue: 3
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib313
  article-title: Drug resistance in cancer: an overview
  publication-title: Cancers
  doi: 10.3390/cancers6031769
– volume: 40
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib317
  article-title: Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer
  publication-title: Nanomed.: Nanotechnol., Biol. Med.
  doi: 10.1016/j.nano.2021.102494
– volume: 12
  start-page: 3537
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib342
  article-title: miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-07468-x
– volume: 80
  issue: 16_Supplement
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib232
  article-title: Ectopic expression of miR-142-3p suppresses growth, migration, colony formation and induces apoptosis by down-regulating HMGA1, HMGA2, HMGB1 and HMGB3 in human cervical cancer cells
  publication-title: Cancer Res.
  doi: 10.1158/1538-7445.AM2020-2517
– year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib46
  article-title: Biological function and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and challenges
  publication-title: Pharmacol. Res.
– volume: 504
  start-page: 196
  issue: 1
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib239
  article-title: High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2018.08.155
– volume: 2
  start-page: 141
  issue: 2
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib314
  article-title: Drug resistance and combating drug resistance in cancer
  publication-title: Cancer Drug Resist.
– volume: 24
  start-page: 112
  issue: 3
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib325
  article-title: miR-205 Reverses MDR-1 Mediated Doxorubicin Resistance via PTEN in Human Liver Cancer HepG2 Cells
  publication-title: Cell J. (Yakhteh)
– volume: 23
  start-page: 255
  issue: 2
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib137
  article-title: HMGA 2 is associated with the aggressiveness of tongue squamous cell carcinoma
  publication-title: Oral. Dis.
  doi: 10.1111/odi.12608
– volume: 14
  start-page: 5908
  issue: 14
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib86
  article-title: microRNA-497 prevents pancreatic cancer stem cell gemcitabine resistance, migration, and invasion by directly targeting nuclear factor kappa B 1
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.204193
– volume: 21
  start-page: 869
  issue: 3
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib353
  article-title: Cationic polymer nanoparticles-mediated delivery of miR-124 impairs tumorigenicity of prostate cancer cells
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21030869
– volume: 244
  start-page: 107
  issue: 1
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib44
  article-title: MicroRNA‐495–3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis
  publication-title: J. Pathol.
  doi: 10.1002/path.4994
– volume: 7
  start-page: 3226
  issue: 7
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib247
  article-title: HMGA 2 promotes glioma invasion and poor prognosis via a long‐range chromatin interaction
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1534
– volume: 6
  start-page: 57
  issue: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib18
  article-title: Role of miR-944/MMP10/AXL-axis in lymph node metastasis in tongue cancer. Communications
  publication-title: Biology
– volume: 27
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib76
  article-title: lncRNA ROR promotes gastric cancer drug resistance
  publication-title: Cancer Control
  doi: 10.1177/1073274820904694
– volume: 11
  start-page: 11937
  issue: 24
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib135
  article-title: Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.102519
– volume: 13
  start-page: 2701
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib157
  article-title: LINC02476 promotes the malignant phenotype of hepatocellular carcinoma by sponging miR-497 and increasing HMGA2 expression
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S237069
– volume: 7
  start-page: 842
  issue: 3
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib209
  article-title: Lnc RNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR‐20a‐5p/HMGA 2 axis in breast cancer
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1353
– volume: 25
  start-page: 79
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib301
  article-title: MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway
  publication-title: Cancer Biomark.
  doi: 10.3233/CBM-182315
– volume: 39
  start-page: 7
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib367
  article-title: LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20182101
– volume: 19
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib43
  article-title: MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-019-0875-1
– volume: 39
  start-page: 234
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib327
  article-title: MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer
  publication-title: Oncogene
  doi: 10.1038/s41388-019-0986-0
– volume: 93
  start-page: 1331
  issue: 12
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib269
  article-title: Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis
  publication-title: Lab. Investig.
  doi: 10.1038/labinvest.2013.120
– volume: 95
  start-page: 331
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib64
  article-title: hu Zhang F, Shen N. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.08.057
– volume: 376
  start-page: 284
  issue: 2
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib193
  article-title: Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2016.04.005
– volume: 5
  start-page: 264
  issue: 2
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib194
  article-title: WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
  publication-title: EMBO Mol. Med.
  doi: 10.1002/emmm.201201320
– volume: 23
  start-page: 23
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib41
  article-title: IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2
  publication-title: Gastric Cancer
  doi: 10.1007/s10120-019-00976-2
– volume: 13
  start-page: 2501
  issue: 5
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib146
  article-title: Propofol inhibits hepatocellular carcinoma growth and invasion through the HMGA2–mediated Wnt/β‑catenin pathway
  publication-title: Exp. Ther. Med.
  doi: 10.3892/etm.2017.4253
– volume: 24
  start-page: 5391
  issue: 10
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib136
  article-title: LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 13
  start-page: 12829
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib160
  article-title: Tumor-linked macrophages promote HCC development by mediating the CCAT1/Let-7b/HMGA2 signaling pathway
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S283786
– volume: 10
  start-page: 94
  issue: 3
  year: 1994
  ident: 10.1016/j.phrs.2023.106732_bib30
  article-title: HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
  publication-title: Trends Genet.
  doi: 10.1016/0168-9525(94)90232-1
– volume: 12
  start-page: 1
  issue: 6
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib72
  article-title: METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer
  publication-title: Cell death Dis.
  doi: 10.1038/s41419-021-03891-6
– volume: 51
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib228
  article-title: MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2
  publication-title: Biol. Res.
  doi: 10.1186/s40659-018-0199-y
– volume: 5
  start-page: 1
  issue: 1
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib91
  article-title: Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
  publication-title: Sci. Rep.
  doi: 10.1038/srep13827
– volume: 65
  start-page: 118
  issue: 7
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib95
  article-title: MicroRNA-101-3p regulates gastric cancer cell proliferation, invasion and apoptosis by targeting PIM 1 expression
  publication-title: Cell. Mol. Biol.
  doi: 10.14715/cmb/2019.65.7.20
– volume: 37
  start-page: 185
  issue: 1
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib39
  article-title: HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2016.5255
– volume: 8
  start-page: 2484
  issue: 5
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib362
  article-title: Long non‐coding RNA PCAT6 targets miR‐204 to modulate the chemoresistance of colorectal cancer cells to 5–fluorouracil‐based treatment through HMGA2 signaling
  publication-title: Cancer Med.
  doi: 10.1002/cam4.1809
– volume: 11
  start-page: 1
  issue: 7
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib175
  article-title: HMGA2 regulates circular RNA ASPH to promote tumor growth in lung adenocarcinoma
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-2726-3
– volume: 610
  start-page: 25
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib200
  article-title: RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1016/j.abb.2016.09.007
– volume: 152
  start-page: 199
  issue: 1
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib208
  article-title: Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-015-3431-2
– volume: 12
  start-page: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib316
  article-title: DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
  publication-title: Clin. Epigenet.
  doi: 10.1186/s13148-020-0821-z
– volume: 19
  start-page: 1463
  issue: 3
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib184
  article-title: MiR‑495 suppresses cell proliferation by directly targeting HMGA2 in lung cancer
  publication-title: Mol. Med. Rep.
– volume: 123
  start-page: 348
  issue: 2
  year: 2008
  ident: 10.1016/j.phrs.2023.106732_bib224
  article-title: HMGA2 gene is a promising target for ovarian cancer silencing therapy
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.23491
– volume: 229
  start-page: 53
  issue: 1
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib223
  article-title: High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer
  publication-title: J. Cell. Physiol.
– volume: 36
  start-page: 2051
  issue: 5
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib293
  article-title: The down-regulation of microRNA-497 contributes to cell growth and cisplatin resistance through PI3K/Akt pathway in osteosarcoma
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000430172
– start-page: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib17
  article-title: HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway
  publication-title: Gastric Cancer
– volume: 9
  start-page: 1784
  issue: 10
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib149
  article-title: Micro RNA‐9 exerts antitumor effects on hepatocellular carcinoma progression by targeting HMGA 2
  publication-title: FEBS Open Bio
  doi: 10.1002/2211-5463.12716
– volume: 20
  start-page: 1
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib364
  article-title: Knockdown circTRIM28 enhances tamoxifen sensitivity via the miR-409-3p/HMGA2 axis in breast cancer
  publication-title: Reprod. Biol. Endocrinol.
  doi: 10.1186/s12958-022-01011-3
– volume: 8
  issue: 3
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib51
  article-title: miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2017.134
– volume: 126
  start-page: 551
  issue: 4
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib211
  article-title: Expression and functions of long non-coding RNA NEAT1 and isoforms in breast cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-021-01588-3
– volume: 20
  start-page: 4452
  issue: 21
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib296
  article-title: Expression and significances of MiRNA Let-7 and HMGA2 in laryngeal carcinoma
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 24
  start-page: 957
  issue: 10
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib266
  article-title: Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high‐grade glioma
  publication-title: CNS Neurosci. Ther.
  doi: 10.1111/cns.12850
– volume: 66
  start-page: 4361
  issue: 12
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib154
  article-title: Circular RNA circZFR promotes hepatocellular carcinoma progression by regulating miR-375/HMGA2 axis
  publication-title: Dig. Dis. Sci.
  doi: 10.1007/s10620-020-06805-2
– volume: 12
  start-page: 10993
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib235
  article-title: Circ_0109046 promotes the progression of endometrial cancer via regulating miR-136/HMGA2 axis
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S274856
– volume: 12
  issue: 5
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib335
  article-title: Exosome‐transmitted miR‐769–5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53
  publication-title: Clin. Transl. Med.
  doi: 10.1002/ctm2.780
– volume: 109
  start-page: 93
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib328
  article-title: MicroRNA-20a-5p inhibits the autophagy and cisplatin resistance in ovarian cancer via regulating DNMT3B-mediated DNA methylation of RBP1
  publication-title: Reprod. Toxicol.
  doi: 10.1016/j.reprotox.2021.12.011
– volume: 192
  start-page: 353
  issue: 2
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib25
  article-title: Tumor-promoting mechanisms of macrophage-derived extracellular vesicles-enclosed microRNA-660 in breast cancer progression
  publication-title: Breast Cancer Res. Treat.
  doi: 10.1007/s10549-021-06433-y
– volume: 12
  start-page: 1
  issue: 5
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib108
  article-title: A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-03753-1
– volume: 19
  start-page: 267
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib186
  article-title: Hydrophobically modified let-7b miRNA enhances biodistribution to NSCLC and downregulates HMGA2 in vivo
  publication-title: Mol. Ther. -Nucleic Acids
  doi: 10.1016/j.omtn.2019.11.008
– volume: 10
  start-page: 1151
  issue: 3
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib352
  article-title: Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer
  publication-title: Theranostics
  doi: 10.7150/thno.38327
– volume: 8
  start-page: 405
  issue: 3
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib150
  article-title: MicroRNA-337 regulates the PI3K/AKT and Wnt/β-catenin signaling pathways to inhibit hepatocellular carcinoma progression by targeting high-mobility group AT-hook 2
  publication-title: Am. J. Cancer Res.
– volume: 47
  start-page: 146
  issue: 2
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib216
  article-title: Expression of HMGA 2 in bladder cancer and its association with epithelial‐to‐mesenchymal transition
  publication-title: Cell Prolif.
  doi: 10.1111/cpr.12096
– volume: 12
  start-page: 877
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib350
  article-title: Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer
  publication-title: Nanoscale
  doi: 10.1039/C9NR09011H
– volume: 8
  start-page: 501
  issue: 5
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib172
  article-title: HMGA 2 regulates lung cancer proliferation and metastasis
  publication-title: Thorac. Cancer
  doi: 10.1111/1759-7714.12476
– volume: 133
  start-page: 2585
  issue: 11
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib298
  article-title: Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis
  publication-title: J. Invest. Dermatol.
  doi: 10.1038/jid.2013.197
– volume: 51
  issue: 8
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib133
  article-title: High‐mobility group AT‐hook 2 promotes growth and metastasis and is regulated by miR‐204–5p in oesophageal squamous cell carcinoma
  publication-title: Eur. J. Clin. Investig.
  doi: 10.1111/eci.13563
– volume: 117
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib276
  article-title: MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2019.108998
– volume: 233
  start-page: 8630
  issue: 11
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib65
  article-title: Long non‐coding RNA FEZF1–AS1 promotes breast cancer stemness and tumorigenesis via targeting miR‐30a/Nanog axis
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.26611
– volume: 10
  start-page: 129
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib42
  article-title: Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S114303
– volume: 18
  start-page: 4
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib142
  article-title: The ceRNA network of lncRNA and miRNA in lung cancer
  publication-title: Genom. Inform.
  doi: 10.5808/GI.2020.18.4.e36
– volume: 37
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib234
  article-title: miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-018-0686-6
– volume: 21
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib128
  article-title: LINC00963 affects the development of colorectal cancer via MiR-532-3p/HMGA2 axis
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01706-w
– volume: 12
  start-page: 1
  issue: 10
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib99
  article-title: Long non-coding RNA ZFAS1 promotes pancreatic cancer proliferation and metastasis by sponging miR-497-5p to regulate HMGA2 expression
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-04123-7
– volume: 13
  start-page: 1003
  issue: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib19
  article-title: Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-023-27415-8
– volume: 12
  start-page: 963
  issue: 2
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib111
  article-title: HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment
  publication-title: Theranostics
  doi: 10.7150/thno.65411
– year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib11
  article-title: Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives
  publication-title: Pharmacol. Res.
– volume: 23
  issue: 919
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib78
  article-title: Long non-coding RNA reprogramming (ROR) promotes cell proliferation in colorectal cancer via affecting P53
  publication-title: Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res.
– start-page: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib47
  article-title: Targeting PI3K/Akt signaling in prostate cancer therapy
  publication-title: J. Cell Commun. Signal.
– volume: 86
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib92
  article-title: Hsa_circ_0136666 activates Treg-mediated immune escape of colorectal cancer via miR-497/PD-L1 pathway
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2021.110095
– volume: 43
  start-page: 1157
  issue: 3
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib94
  article-title: lncRNA SNHG1 negatively regulates miRNA‑101–3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma
  publication-title: Int. J. Mol. Med.
– volume: 59
  start-page: 1648
  issue: 6
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib202
  article-title: CircARL8B Contributes to the Development of Breast Cancer Via Regulating miR-653-5p/HMGA2 Axis
  publication-title: Biochem. Genet.
  doi: 10.1007/s10528-021-10082-7
– volume: 36
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib321
  article-title: SOX4 induces drug resistance of colorectal cancer cells by downregulating CYLD through transcriptional activation of microRNA‐17
  publication-title: J. Biochem. Mol. Toxicol.
  doi: 10.1002/jbt.22910
– volume: 6
  start-page: 249
  issue: 2
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib233
  article-title: Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis
  publication-title: Am. J. Cancer Res.
– volume: 140
  start-page: 225
  issue: 2
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib267
  article-title: Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway
  publication-title: J. Neuro-Oncol.
  doi: 10.1007/s11060-018-2951-0
– volume: 126
  start-page: 503
  issue: 3
  year: 2006
  ident: 10.1016/j.phrs.2023.106732_bib5
  article-title: A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation
  publication-title: Cell
  doi: 10.1016/j.cell.2006.05.052
– volume: 44
  start-page: 2050
  issue: 6
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib307
  article-title: MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2014.2360
– volume: 49
  start-page: 1
  issue: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib16
  article-title: MicroRNAs as early diagnostic biomarkers for non‑small cell lung cancer
  publication-title: Oncol. Rep.
– volume: 11
  start-page: 1482
  issue: 10
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib109
  article-title: An integrated bioinformatics analysis repurposes an antihelminthic drug niclosamide for treating HMGA2-overexpressing human colorectal cancer
  publication-title: Cancers
  doi: 10.3390/cancers11101482
– volume: 72
  start-page: 1102
  issue: 7
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib297
  article-title: HMGA 2, but not HMGA 1, is overexpressed in human larynx carcinomas
  publication-title: Histopathology
  doi: 10.1111/his.13456
– volume: 37
  start-page: 699
  issue: 1
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib238
  article-title: Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-015-3853-9
– volume: 50
  start-page: 58.5
  issue: 31
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib259
  article-title: Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε
  publication-title: Age (years)
– volume: 154
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib8
  article-title: LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2022.113609
– volume: 21
  start-page: 1025
  issue: 9
  year: 2007
  ident: 10.1016/j.phrs.2023.106732_bib178
  article-title: The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
  publication-title: Genes Dev.
  doi: 10.1101/gad.1540407
– volume: 7
  start-page: 25872
  issue: 18
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib272
  article-title: HMGA2 overexpression plays a critical role in the progression of esophageal squamous carcinoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8288
– volume: 14
  issue: 1
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib107
  article-title: Emerging roles for HMGA2 in colorectal cancer
  publication-title: Transl. Oncol.
  doi: 10.1016/j.tranon.2020.100894
– volume: 3
  start-page: 1439
  issue: 11
  year: 2012
  ident: 10.1016/j.phrs.2023.106732_bib257
  article-title: Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.683
– volume: 29
  start-page: 1021
  issue: 10
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib275
  article-title: Biomarker function of HMGA2 in ultraviolet‐induced skin cancer development
  publication-title: Exp. Dermatol.
  doi: 10.1111/exd.14174
– volume: 39
  issue: 10
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib167
  article-title: Roles of microRNA let-7b in papillary thyroid carcinoma by regulating HMGA2
  publication-title: Tumor Biol.
  doi: 10.1177/1010428317719274
– start-page: 11
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib229
  article-title: ER-α36 promotes the malignant progression of cervical cancer mediated by estrogen via HMGA2
  publication-title: Front. Oncol.
– volume: 41
  start-page: 1022
  issue: 7
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib219
  article-title: miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2
  publication-title: Nan Fang. yi ke da xue xue bao= J. South. Med. Univ.
– volume: 18
  start-page: 685
  issue: 5
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib81
  article-title: OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2OLR1–c-Myc–HMGA2 Promotes Metastasis in Pancreatic Cancer
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-19-0718
– volume: 15
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib341
  article-title: MicroRNA-19b downregulates NR3C1 and enhances oxaliplatin chemoresistance in colon cancer via the PI3K/AKT/mTOR pathway
  publication-title: Clin. Med. Insight.: Oncol.
– volume: 39
  start-page: 9
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib242
  article-title: Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20190635
– volume: 21
  start-page: 1
  issue: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib345
  article-title: The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
  publication-title: Cell Commun. Signal.
  doi: 10.1186/s12964-022-01017-9
– volume: 222
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib148
  article-title: miR-760 mediated the proliferation and metastasis of hepatocellular carcinoma cells by regulating HMGA2
  publication-title: Pathol. -Res. Pract.
  doi: 10.1016/j.prp.2021.153420
– volume: 499
  start-page: 75
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib70
  article-title: Long noncoding RNA OIP5-AS1 in cancer
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2019.08.031
– volume: 10
  start-page: 6037
  issue: 24
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib116
  article-title: Dichloroacetate overcomes oxaliplatin chemoresistance in colorectal cancer through the miR-543/PTEN/Akt/mTOR pathway
  publication-title: J. Cancer
  doi: 10.7150/jca.34650
– volume: 7
  start-page: 862
  issue: 7
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib274
  article-title: ANG promotes proliferation and invasion of the cell of lung squamous carcinoma by directly up-regulating HMGA2
  publication-title: J. Cancer
  doi: 10.7150/jca.14440
– volume: 18
  start-page: 2317
  issue: 11
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib207
  article-title: The long noncoding RNA HOTAIR in breast cancer: does autophagy play a role?
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms18112317
– volume: 308
  start-page: 44
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib356
  article-title: Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2019.07.006
– volume: 13
  start-page: 1
  issue: 1
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib304
  article-title: Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-015-0462-8
– volume: 33
  start-page: 123
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib50
  article-title: LncRNA SNHG8 promotes proliferation and invasion of gastric cancer cells by targeting the miR-491/PDGFRA axis
  publication-title: Hum. Cell
  doi: 10.1007/s13577-019-00290-0
– volume: 25
  start-page: 17674
  issue: 18
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib265
  article-title: LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression
  publication-title: Environ. Sci. Pollut. Res.
  doi: 10.1007/s11356-018-1784-x
– volume: 8
  start-page: 21554
  issue: 13
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib226
  article-title: Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.15795
– volume: 76
  start-page: 539
  issue: 3
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib227
  article-title: Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5
  publication-title: Cell. Mol. Life Sci.
  doi: 10.1007/s00018-018-2958-x
– volume: 11
  start-page: 2332
  issue: 15
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib343
  article-title: MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention
  publication-title: Cells
  doi: 10.3390/cells11152332
– volume: 37
  start-page: 168
  issue: 3
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib348
  article-title: Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy
  publication-title: J. Bioact. Compat. Polym.
  doi: 10.1177/08839115221095152
– volume: 8
  start-page: 2115
  issue: 12
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib337
  article-title: Molecular insights into miRNA-driven resistance to 5-fluorouracil and oxaliplatin chemotherapy: miR-23b modulates the epithelial–mesenchymal transition of colorectal cancer cells
  publication-title: J. Clin. Med.
  doi: 10.3390/jcm8122115
– volume: 7
  start-page: 899
  issue: 12
  year: 2007
  ident: 10.1016/j.phrs.2023.106732_bib7
  article-title: Roles of HMGA proteins in cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc2271
– volume: 22
  start-page: 8353
  issue: 23
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib177
  article-title: The role of let-7 and HMGA2 in the occurrence and development of lung cancer: a systematic review and meta-analysis
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 118
  start-page: 449
  issue: 8
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib292
  article-title: MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway
  publication-title: Bratisl. Lek. Listy
– volume: 34
  start-page: 3617
  issue: 28
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib310
  article-title: Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
  publication-title: Oncogene
  doi: 10.1038/onc.2014.314
– volume: 96
  start-page: 1103
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib67
  article-title: Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2017.11.113
– volume: 17
  start-page: 7451
  issue: 5
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib308
  article-title: MicroRNA-599 targets high-mobility group AT-hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma
  publication-title: Mol. Med. Rep.
– volume: 13
  start-page: 1241
  issue: 4
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib90
  article-title: miR-497-5p-RSPO2 axis inhibits cell growth and metastasis in glioblastoma
  publication-title: J. Cancer
  doi: 10.7150/jca.62652
– volume: 292
  start-page: 15395
  issue: 37
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib161
  article-title: The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M117.783738
– volume: 12
  start-page: 24957
  issue: 24
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib294
  article-title: LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.103464
– ident: 10.1016/j.phrs.2023.106732_bib105
  doi: 10.1158/1541-7786.c.6545664
– volume: 40
  start-page: 6
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib277
  article-title: Molecular mechanism of targeted inhibition of HMGA2 via miRNAlet-7a in proliferation and metastasis of laryngeal squamous cell carcinoma
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20193788
– volume: 23
  start-page: 1
  issue: 6
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib214
  article-title: Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524–5p/HMGA2 axis
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2021.12085
– volume: 24
  start-page: 1824
  issue: 3
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib26
  article-title: MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms24031824
– volume: 10
  start-page: 177
  issue: 4
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib151
  article-title: Downregulation of miR-196-5p induced by hypoxia drives tumorigenesis and metastasis in hepatocellular carcinoma
  publication-title: Horm. Cancer
  doi: 10.1007/s12672-019-00370-5
– volume: 23
  start-page: 1
  issue: 5
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib28
  article-title: MicroRNA‑20a promotes non‑small cell lung cancer proliferation by upregulating PD‑L1 by targeting PTEN
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2022.13269
– volume: 13
  start-page: 5197
  issue: 20
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib191
  article-title: HMGA2 supports cancer hallmarks in triple-negative breast cancer
  publication-title: Cancers
  doi: 10.3390/cancers13205197
– volume: 24
  start-page: 2901
  issue: 5
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib369
  article-title: Verbascoside inhibits progression of glioblastoma cells by promoting Let‐7g‐5p and down‐regulating HMGA2 via Wnt/beta‐catenin signalling blockade
  publication-title: J. Cell. Mol. Med.
  doi: 10.1111/jcmm.14884
– volume: 9
  start-page: 459
  issue: 6
  year: 2006
  ident: 10.1016/j.phrs.2023.106732_bib33
  article-title: HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.04.024
– volume: 46
  start-page: 1
  issue: 5
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib117
  article-title: Identification of the tumor‑suppressive role of circular RNA‑FOXO3 in colorectal cancer via regulation of miR‑543/LATS1 axis
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2021.8190
– volume: 9
  start-page: 2
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib305
  article-title: Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma
  publication-title: Ann. Transl. Med.
– volume: 30
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib206
  article-title: LncRNA HOTAIR promotes the proliferation and invasion/metastasis of breast cancer cells by targeting the miR-130a-3p/Suv39H1 axis
  publication-title: Biochem. Biophys. Rep.
– volume: 33
  start-page: 2675
  issue: 6
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib280
  article-title: HMGA2 expression pattern and TERT mutations in tumors of the vulva
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2015.3882
– volume: 18
  start-page: 2524
  issue: 19
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib159
  article-title: Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2019.1652035
– volume: 14
  start-page: 3818
  issue: 15
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib346
  article-title: miRacle of microRNA-Driven Cancer Nanotherapeutics
  publication-title: Cancers
  doi: 10.3390/cancers14153818
– volume: 67
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib347
  article-title: Functionalized PAMAM-Based system for targeted delivery of miR-205 and 5-fluorouracil in breast cancer
  publication-title: J. Drug Deliv. Sci. Technol.
– volume: 27
  start-page: 471
  issue: 6
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib164
  article-title: HMGA2 gene expression in fine-needle aspiration samples of thyroid nodules as a marker for preoperative diagnosis of thyroid cancer
  publication-title: Appl. Immunohistochem. Mol. Morphol.
  doi: 10.1097/PAI.0000000000000637
– year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib10
  article-title: Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2022.09.203
– volume: 11
  start-page: 1427
  issue: 5
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib264
  article-title: FoxD2-AS1 promotes glioma progression by regulating miR-185–5 P/HMGA2 axis and PI3K/AKT signaling pathway
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.101843
– volume: 19
  start-page: 935
  issue: 2
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib147
  article-title: MicroRNA‑363–3p inhibits hepatocarcinogenesis by targeting HMGA2 and is associated with liver cancer stage
  publication-title: Mol. Med. Rep.
– volume: 377
  start-page: 55
  issue: 1
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib243
  article-title: The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2016.04.020
– volume: 21
  start-page: 3610
  issue: 10
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib250
  article-title: Mir-370-3p impairs glioblastoma stem-like cell malignancy regulating a complex interplay between HMGA2/HIF1A and the oncogenic long non-coding RNA (lncRNA) NEAT1
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21103610
– volume: 12
  start-page: 370
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib189
  article-title: Long noncoding RNA VPS9D1-AS1 augments the malignant phenotype of non-small cell lung cancer by sponging microRNA-532-3p and thereby enhancing HMGA2 expression
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.102628
– volume: 14
  start-page: 601
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib245
  article-title: Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children
  publication-title: Pharm. Pers. Med.
– volume: 16
  start-page: 3557
  issue: 3
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib180
  article-title: MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2
  publication-title: Mol. Med. Rep.
  doi: 10.3892/mmr.2017.7000
– volume: 932
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib38
  article-title: Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
  publication-title: Eur. J. Pharmacol.
  doi: 10.1016/j.ejphar.2022.175212
– volume: 7
  start-page: 21825
  issue: 16
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib118
  article-title: MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7989
– volume: 118
  start-page: 287
  issue: 5
  year: 2010
  ident: 10.1016/j.phrs.2023.106732_bib165
  article-title: HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules
  publication-title: Cancer Cytopathol.
  doi: 10.1002/cncy.20095
– volume: 13
  start-page: 714
  issue: 10
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib315
  article-title: Cancer drug resistance: an evolving paradigm
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3599
– volume: 2
  start-page: 5
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib3
  article-title: HMGA proteins as modulators of chromatin structure during transcriptional activation
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2014.00005
– volume: 7
  start-page: 11271
  issue: 10
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib63
  article-title: Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7168
– volume: 9
  start-page: 1526
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib80
  article-title: HMGA2 antisense long non-coding RNAs as new players in the regulation of HMGA2 expression and pancreatic cancer promotion
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2019.01526
– start-page: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib21
  article-title: MicroRNA-10a-5p targets SERPINE1 to suppress cell progression and epithelial–mesenchymal transition process in clear cell renal cell carcinoma
  publication-title: Mol. Cell. Toxicol.
– volume: 16
  start-page: 675
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib182
  article-title: miR-150-5p inhibits non-small-cell lung cancer metastasis and recurrence by targeting HMGA2 and β-catenin signaling
  publication-title: Mol. Ther. -Nucleic Acids
  doi: 10.1016/j.omtn.2019.04.017
– volume: 20
  start-page: 2473
  issue: 10
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib268
  article-title: HMGA2 contributes to distant metastasis and poor prognosis by promoting angiogenesis in oral squamous cell carcinoma
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20102473
– volume: 121
  start-page: 2543
  issue: 3
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib162
  article-title: SNHG16 as the miRNA let‐7b‐5p sponge facilitates the G2/M and epithelial‐mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.29477
– volume: 12
  start-page: 1197
  issue: 5
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib205
  article-title: Long non-coding RNA HOTAIR in breast cancer therapy
  publication-title: Cancers
  doi: 10.3390/cancers12051197
– volume: 7
  start-page: 289
  issue: 4
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib225
  article-title: Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells
  publication-title: Asian Pac. J. Trop. Med.
  doi: 10.1016/S1995-7645(14)60040-7
– volume: 38
  start-page: 7399
  issue: 49
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib256
  article-title: An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme
  publication-title: Oncogene
  doi: 10.1038/s41388-019-0952-x
– ident: 10.1016/j.phrs.2023.106732_bib74
– volume: 9
  start-page: 3
  issue: 1
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib20
  article-title: Mesenchymal stem cell-derived extracellular vesicles transfer miR-598 to inhibit the growth and metastasis of non-small-cell lung cancer by targeting THBS2
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-022-01283-z
– volume: 137
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib69
  article-title: A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2021.111366
– volume: 10
  start-page: 1
  issue: 2
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib114
  article-title: P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-018-1188-3
– volume: 24
  start-page: 905
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib236
  article-title: lncRNA MIR210HG promotes the progression of endometrial cancer by sponging miR-337-3p/137 via the HMGA2-TGF-β/Wnt pathway
  publication-title: Mol. Ther. -Nucleic Acids
  doi: 10.1016/j.omtn.2021.04.011
– volume: 5
  start-page: 1353
  issue: 4
  year: 2013
  ident: 10.1016/j.phrs.2023.106732_bib144
  article-title: HMGA2 induces epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2013.1193
– year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib309
  article-title: LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR‐103a
  publication-title: J. Clin. Lab. Anal.
  doi: 10.1002/jcla.24422
– volume: 1049
  start-page: 231
  issue: 3
  year: 1990
  ident: 10.1016/j.phrs.2023.106732_bib31
  article-title: Structural features of the HMG chromosomal proteins and their genes
  publication-title: Biochim. Et. Biophys. Acta (BBA)-Gene Struct. Expr.
  doi: 10.1016/0167-4781(90)90092-G
– volume: 35
  start-page: 9163
  issue: 9
  year: 2014
  ident: 10.1016/j.phrs.2023.106732_bib106
  article-title: H19 promotes pancreatic cancer metastasis by derepressing let-7’s suppression on its target HMGA2-mediated EMT
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-014-2185-5
– volume: 24
  start-page: 6639
  issue: 12
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib97
  article-title: LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 1644
  start-page: 53
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib252
  article-title: MicroRNA-370-3p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting β-catenin
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2016.04.066
– ident: 10.1016/j.phrs.2023.106732_bib171
  doi: 10.1002/mc.20235
– volume: 24
  start-page: 4710
  issue: 9
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib240
  article-title: MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 8
  start-page: 1
  issue: 1
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib79
  article-title: Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-32159-x
– volume: 37
  start-page: 12867
  issue: 9
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib77
  article-title: Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion
  publication-title: Tumor Biol.
  doi: 10.1007/s13277-016-5210-z
– volume: 44
  start-page: 1015
  issue: 7
  year: 2008
  ident: 10.1016/j.phrs.2023.106732_bib166
  article-title: HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2008.02.039
– volume: 43
  start-page: 840
  issue: 2
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib102
  article-title: CXCR4/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000481610
– volume: 43
  start-page: 682
  issue: 7
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib27
  article-title: Exosomal microRNA-23b-3p promotes tumor angiogenesis and metastasis by targeting PTEN in salivary adenoid cystic carcinoma
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgac033
– volume: 5
  start-page: 1
  issue: 1
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib270
  article-title: Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma
  publication-title: Sci. Rep.
– volume: 9
  start-page: 8927
  issue: 10
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib278
  article-title: Let-7c inhibits migration and epithelial–mesenchymal transition in head and neck squamous cell carcinoma by targeting IGF1R and HMGA2
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23826
– volume: 17
  start-page: 1149
  issue: 11
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib120
  article-title: MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2
  publication-title: Cancer Biol. Ther.
  doi: 10.1080/15384047.2016.1235661
– volume: 6
  start-page: 1
  issue: 1
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib251
  article-title: Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
  publication-title: Sci. Rep.
– volume: 17
  start-page: 1330
  issue: 2
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib57
  article-title: MicroRNA‑490–3p regulates cell proliferation and apoptosis in gastric cancer via direct targeting of AKT1
  publication-title: Exp. Ther. Med.
– volume: 29
  start-page: 803
  issue: 6
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib22
  article-title: MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway
  publication-title: Cancer Gene Ther.
  doi: 10.1038/s41417-021-00362-0
– volume: 1
  start-page: 169
  issue: 2
  year: 2012
  ident: 10.1016/j.phrs.2023.106732_bib125
  article-title: The roles of miRNA-143 in colon cancer and therapeutic implications. Transl Gastrointest
  publication-title: Cancer
– volume: 20
  start-page: 1080
  issue: 11
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib359
  article-title: HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2021.1924948
– volume: 5
  start-page: 563
  issue: 5
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib360
  article-title: MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2
  publication-title: Biol. Open
  doi: 10.1242/bio.015008
– volume: 33
  start-page: 448
  issue: 5
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib134
  article-title: Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis
  publication-title: Anti-Cancer Drugs
  doi: 10.1097/CAD.0000000000001284
– volume: 12
  start-page: 835
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib96
  article-title: miRNA-101-5p inhibits the growth and aggressiveness of NSCLC cells through targeting CXCL6
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S184235
– start-page: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib336
  article-title: Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer
  publication-title: Br. J. Cancer
– volume: 14
  start-page: 1620
  issue: 8
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib344
  article-title: Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics14081620
– volume: 74
  start-page: 301
  issue: 5
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib145
  article-title: Angiogenin regulates epithelial-mesenchymal transition of hepatocellular carcinoma through upregulation of HMGA2. Die Pharmazie-An
  publication-title: Int. J. Pharm. Sci.
– volume: 8
  start-page: 25167
  issue: 15
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib258
  article-title: Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.15531
– volume: 20
  start-page: 1
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib284
  article-title: Circular RNA circUBAP2 regulates proliferation and invasion of osteosarcoma cells through miR-641/YAP1 axis
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01318-4
– volume: 8
  start-page: 169
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib302
  article-title: HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S74397
– start-page: 838
  year: 2002
  ident: 10.1016/j.phrs.2023.106732_bib29
  article-title: High-mobility-group chromosomal proteins, HMGA1 as potential tumour markers
  publication-title: Curr. Sci.
– volume: 35
  start-page: 720
  issue: 9
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib140
  article-title: Downregulation of lncRNA HOTTIP suppresses the proliferation, migration, and invasion of oral tongue squamous cell carcinoma by regulation of HMGA2-mediated Wnt/β-catenin pathway
  publication-title: Cancer Biotherapy Radiopharm.
  doi: 10.1089/cbr.2019.3017
– volume: 23
  start-page: 3461
  issue: 13
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib40
  article-title: HMGA2–FOXL2 Axis Regulates Metastases and Epithelial-to-Mesenchymal Transition of Chemoresistant Gastric CancerHMGA2–FOXL2 Pathway Promotes Metastases and EMT in GC
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-16-2180
– volume: 46
  start-page: 609
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib329
  article-title: Exosomal microRNA‑146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2–mediated PI3K/Akt axis
  publication-title: Int. J. Mol. Med.
  doi: 10.3892/ijmm.2020.4634
– volume: 19
  start-page: 1
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib88
  article-title: lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4
  publication-title: Cancer Cell Int.
  doi: 10.1186/1475-2867-3-1
– volume: 12
  start-page: 1852
  issue: 7
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib12
  article-title: A comprehensive review of cancer MicroRNA therapeutic delivery strategies
  publication-title: Cancers
  doi: 10.3390/cancers12071852
– volume: 235
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib188
  article-title: Circ_0000514 promotes the malignant biological behaviors of non-small cell lung cancer cells by modulating miR-330-5p and HMGA2
  publication-title: Pathol. -Res. Pract.
  doi: 10.1016/j.prp.2022.153913
– volume: 28
  start-page: 203
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib93
  article-title: MiRNA-101 targets TGF-βR1 to retard the progression of oral squamous cell carcinoma
  publication-title: Oncol. Res.
  doi: 10.3727/096504019X15761480623959
– volume: 22
  start-page: e286
  issue: 3
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib201
  article-title: Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2
  publication-title: Clin. Breast Cancer
  doi: 10.1016/j.clbc.2021.08.009
– volume: 34
  issue: 2
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib168
  article-title: miR‐98–5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase‐3 by HMGA2
  publication-title: J. Clin. Lab. Anal.
  doi: 10.1002/jcla.23044
– volume: 37
  start-page: 265
  issue: 3
  year: 2011
  ident: 10.1016/j.phrs.2023.106732_bib217
  article-title: Overexpression of HMGA2 in bladder cancer and its association with clinicopathologic features and prognosis: HMGA2 as a prognostic marker of bladder cancer
  publication-title: Eur. J. Surg. Oncol. (EJSO)
  doi: 10.1016/j.ejso.2011.01.004
– volume: 35
  start-page: 1529
  issue: 12
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib192
  article-title: Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2
  publication-title: Oncogene
  doi: 10.1038/onc.2015.217
– volume: 40
  start-page: 219
  issue: 1–2
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib75
  article-title: The emerging roles of long noncoding RNA ROR (lincRNA-ROR) and its possible mechanisms in human cancers
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000452539
– volume: 15
  start-page: 2
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib183
  article-title: MicroRNA-154 functions as a tumor suppressor and directly targets HMGA2 in human non-small cell lung cancer
  publication-title: Genet Mol. Res
  doi: 10.4238/gmr.15028173
– volume: 11
  start-page: 2207
  issue: 3
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib291
  article-title: MicroRNA‑497 suppresses osteosarcoma tumor growth in vitro and in vivo
  publication-title: Oncol. Lett.
  doi: 10.3892/ol.2016.4162
– volume: 31
  start-page: 209
  issue: 3
  year: 2009
  ident: 10.1016/j.phrs.2023.106732_bib300
  article-title: Expression of high mobility group A2 protein in retinoblastoma and its association with clinicopathologic features
  publication-title: J. Pediatr. Hematol. /Oncol.
  doi: 10.1097/MPH.0b013e318197978d
– year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib55
  article-title: Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: prospects for the therapeutic management of breast cancer
– volume: 234
  start-page: 12809
  issue: 8
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib306
  article-title: Long noncoding RNA HOXC13–AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR‐383–3p/HMGA2 axis
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.27915
– volume: 48
  start-page: 4858
  issue: 9
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib129
  article-title: The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt–PCAF pathway in promotion of esophageal squamous cell carcinoma growth
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkaa232
– volume: 155
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib36
  article-title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2022.113774
– volume: 380
  start-page: 205
  issue: 1
  year: 2016
  ident: 10.1016/j.phrs.2023.106732_bib311
  article-title: Tumor microenvironment and cancer therapy resistance
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2015.07.044
– volume: 38
  start-page: 14
  issue: 1
  year: 1973
  ident: 10.1016/j.phrs.2023.106732_bib2
  article-title: A new group of chromatin‐associated proteins with a high content of acidic and basic amino acids
  publication-title: Eur. J. Biochem.
  doi: 10.1111/j.1432-1033.1973.tb03026.x
– volume: 41
  start-page: 7
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib260
  article-title: LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1
  publication-title: Biosci. Rep.
– volume: 55
  start-page: 775
  issue: 4
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib32
  article-title: Oncological role of HMGA2
  publication-title: Int. J. Oncol.
– ident: 10.1016/j.phrs.2023.106732_bib113
  doi: 10.20944/preprints202110.0289.v1
– volume: 20
  start-page: 1
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib187
  article-title: Circ_100565 promotes proliferation, migration and invasion in non-small cell lung cancer through upregulating HMGA2 via sponging miR-506-3p
  publication-title: Cancer Cell Int.
– volume: 13
  start-page: 6629
  issue: 3
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib169
  article-title: The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2
  publication-title: Bioengineered
  doi: 10.1080/21655979.2022.2044277
– volume: 40
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib58
  article-title: CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-021-01896-9
– year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib218
  article-title: Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
– volume: 158
  start-page: 224
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib288
  article-title: MiR-204-5p promotes apoptosis and inhibits migration of osteosarcoma via targeting EBF2
  publication-title: Biochimie
  doi: 10.1016/j.biochi.2018.12.003
– volume: 18
  start-page: 550
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib339
  article-title: Overexpression of microRNA‑620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD
  publication-title: Exp. Ther. Med.
– volume: 37
  start-page: 1359
  issue: 8
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib261
  article-title: MicroRNA-98 attenuates cell migration and invasion in glioma by directly targeting pre-B cell leukemia homeobox 3
  publication-title: Cell. Mol. Neurobiol.
  doi: 10.1007/s10571-017-0466-4
– volume: 28
  start-page: 483
  issue: 5
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib203
  article-title: Long noncoding RNA LINC02163 accelerates malignant tumor behaviors in breast cancer by regulating the MicroRNA-511-3p/HMGA2 axis
  publication-title: Oncol. Res.
  doi: 10.3727/096504020X15928179818438
– volume: 13
  start-page: 642
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib253
  article-title: miR-370-3p is a therapeutic tool in anti-glioblastoma therapy but is not an intratumoral or cell-free circulating biomarker
  publication-title: Mol. Ther. -Nucleic Acids
  doi: 10.1016/j.omtn.2018.09.007
– volume: 24
  start-page: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib330
  article-title: MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2
  publication-title: Cell. Mol. Biol. Lett.
  doi: 10.1186/s11658-019-0168-7
– volume: 10
  start-page: 525
  issue: 2
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib49
  article-title: MiRNA-491-5p inhibits cell proliferation, invasion and migration via targeting JMJD2B and serves as a potential biomarker in gastric cancer
  publication-title: Am. J. Transl. Res.
– volume: 23
  start-page: 673
  issue: 5
  year: 2010
  ident: 10.1016/j.phrs.2023.106732_bib222
  article-title: HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma
  publication-title: Mod. Pathol.
  doi: 10.1038/modpathol.2010.49
– volume: 22
  start-page: 8298
  issue: 23
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib131
  article-title: MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 51
  start-page: 329
  issue: 4
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib283
  article-title: CircUBAP2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway
  publication-title: J. Mol. Histol.
  doi: 10.1007/s10735-020-09883-8
– volume: 349
  start-page: 712
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib249
  article-title: MicroRNA delivery systems in glioma therapy and perspectives: A systematic review
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2022.07.027
– volume: 108
  start-page: 601
  issue: 3
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib354
  article-title: Layer‐by‐layer assembled PLGA nanoparticles carrying miR‐34a cargo inhibit the proliferation and cell cycle progression of triple‐negative breast cancer cells
  publication-title: J. Biomed. Mater. Res. Part A
  doi: 10.1002/jbm.a.36840
– volume: 14
  start-page: 1
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib289
  article-title: Long noncoding RNA CCDC144NL-AS1 promotes the oncogenicity of osteosarcoma by acting as a molecular sponge for microRNA-490-3p and thereby increasing HMGA2 expression
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S280912
– volume: 21
  start-page: 47
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib319
  article-title: Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-022-01530-y
– volume: 22
  start-page: 424
  issue: 2
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib13
  article-title: miRNA nanotherapeutics for cancer
  publication-title: Drug Discov. Today
  doi: 10.1016/j.drudis.2016.10.014
– volume: 30
  start-page: 81
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib333
  article-title: MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells
  publication-title: Anti-Cancer Drugs
  doi: 10.1097/CAD.0000000000000700
– volume: 575
  start-page: 299
  issue: 7782
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib312
  article-title: A view on drug resistance in cancer
  publication-title: Nature
  doi: 10.1038/s41586-019-1730-1
– volume: 171
  start-page: 389
  issue: 4
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib127
  article-title: Long non-coding RNA DANCR accelerates colorectal cancer progression via regulating the miR-185-5p/HMGA2 axis
  publication-title: J. Biochem.
  doi: 10.1093/jb/mvab011
– volume: 9
  start-page: 6528
  issue: 19
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib355
  article-title: Delivery of miR-320a-3p by gold nanoparticles combined with photothermal therapy for directly targeting Sp1 in lung cancer
  publication-title: Biomater. Sci.
  doi: 10.1039/D1BM01124C
– volume: 7
  start-page: 260
  issue: 2
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib35
  article-title: HMGA2 regulates CD44 expression to promote gastric cancer cell motility and sphere formation
  publication-title: Am. J. Cancer Res.
– volume: 65
  start-page: 1019
  issue: 11
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib130
  article-title: RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: Oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation
  publication-title: J. Hum. Genet.
  doi: 10.1038/s10038-020-0795-x
– volume: 41
  start-page: 1
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib220
  article-title: Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-021-02175-3
– start-page: 2021
  year: 2021
  ident: 10.1016/j.phrs.2023.106732_bib121
  article-title: MicroRNA-let-7 targets HMGA2 to regulate the proliferation, migration, and invasion of colon cancer cell HCT116
  publication-title: Evid. -Based Complement. Altern. Med.: eCAM
– volume: 11
  start-page: 3065
  issue: 19
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib349
  article-title: Hyaluronic Acid-Coated Bovine Milk Exosomes for Achieving Tumor-Specific Intracellular Delivery of miRNA-204
  publication-title: Cells
  doi: 10.3390/cells11193065
– volume: 21
  start-page: 1020
  issue: 5
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib210
  article-title: lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 12
  start-page: 6947
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib139
  article-title: microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S210567
– volume: 25
  start-page: 653
  issue: 7
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib358
  article-title: MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression
  publication-title: J. Drug Target.
  doi: 10.1080/1061186X.2017.1323220
– volume: 12
  issue: 10
  year: 2017
  ident: 10.1016/j.phrs.2023.106732_bib132
  article-title: miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0185636
– volume: 22
  start-page: 1693
  issue: 6
  year: 2018
  ident: 10.1016/j.phrs.2023.106732_bib179
  article-title: Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 463
  start-page: 357
  issue: 3
  year: 2015
  ident: 10.1016/j.phrs.2023.106732_bib303
  article-title: Downregulating HMGA2 attenuates epithelial-mesenchymal transition-induced invasion and migration in nasopharyngeal cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.05.068
– volume: 29
  start-page: 1
  issue: 1
  year: 2022
  ident: 10.1016/j.phrs.2023.106732_bib324
  article-title: MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway
  publication-title: J. Biomed. Sci.
  doi: 10.1186/s12929-022-00824-z
– volume: 12
  start-page: 525
  issue: 4
  year: 2023
  ident: 10.1016/j.phrs.2023.106732_bib15
  article-title: Potential miRNA Use as a Biomarker: From Breast Cancer Diagnosis to Metastasis
  publication-title: Cells
  doi: 10.3390/cells12040525
– volume: 1
  start-page: 1
  issue: 1
  year: 2006
  ident: 10.1016/j.phrs.2023.106732_bib34
  article-title: E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression
  publication-title: Cell Div.
  doi: 10.1186/1747-1028-1-17
– volume: 24
  start-page: 122
  issue: 1
  year: 2020
  ident: 10.1016/j.phrs.2023.106732_bib85
  article-title: MiR-497 inhibits cell proliferation and invasion ability by targeting HMGA2 in pancreatic ductal adenocarcinoma
  publication-title: Eur. Rev. Med Pharm. Sci.
– volume: 452
  start-page: 213
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib197
  article-title: Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2019.03.032
– volume: 18
  start-page: 664
  issue: 1
  year: 2019
  ident: 10.1016/j.phrs.2023.106732_bib254
  article-title: miR‑490–3p functions as a tumor suppressor in glioma by inhibiting high‑mobility group AT‑hook 2 expression
  publication-title: Exp. Ther. Med.
SSID ssj0009410
Score 2.519809
SecondaryResourceType review_article
Snippet High mobility group A 2 (HMGA2) is a protein that modulates the structure of chromatin in the nucleus. Importantly, aberrant expression of HMGA2 occurs during...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 106732
SubjectTerms Cancer
Cell Line, Tumor
CircRNAs
HMGA2
HMGA2 Protein - metabolism
Humans
LncRNA
MicroRNAs - genetics
MicroRNAs - metabolism
MiRNA
Neoplasms - drug therapy
Neoplasms - genetics
RNA, Circular - genetics
RNA, Long Noncoding - metabolism
RNA, Untranslated - genetics
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LTxsxELYqTr1UtNCS0iIjIS7Nll0_495SRIiQiKKKSNwsv1ZKIZsqCYf8-47Xu6E5kF64er3ekWe884088w1CZx6iHm9lmfnAScZ47jNrrMsgbjMK8C53NUnS7UgMJ-zmnt__0-or5oQleuC0cReAAAinpZVBKGZMoUpJiQNYokrhLKtL98DntcFUS7fLirwpkUnZXLAzkZyb0O-RM42SLTdUs_VveaOX0GbtdQb76F0DF3E_ifkevQnVB3Q-TnzT6y6-ey6fWnbxOR4_M1GvD9BkeHvdJ3iR-s2DBrBd49n016i_xNMKu6jxxQ_cr3M6wIc1Izg2WJmZxcMSm8rjVKK1hmXqdNpwiCaDq7vLYdb0UcgcE2KVsSLkwRTU5yWRXObeBsA9Lrc9eE4ssd4pxfLgRID4xvU488oK6ST33NAg6Ee0V82rcISwtbkItpTBGMW49D1iKSOlAVcLztD1Oqhot1W7hmQ89rp41G022W8dVaGjKnRSRQd927zzJ1Fs7Jz9M2prMzPSY9cDYDS6MRr9P6PpIN7qWjdIIyEIWGq68-OnrWFoOIbxbsVUYf4EkyTgTPgbEtFBn5LFbESkQlFAquTza4h-jN5GgVLy0Be0t1o8ha-Ai1b2pD4CfwGe4QpI
  priority: 102
  providerName: Directory of Open Access Journals
Title HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
URI https://dx.doi.org/10.1016/j.phrs.2023.106732
https://www.ncbi.nlm.nih.gov/pubmed/36931542
https://www.proquest.com/docview/2792904826
https://doaj.org/article/951253fb7e694aa19f732c9239f6cb49
Volume 190
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLemceGCGOOjDCpPQruwrIk_a25h2iigVROs0m6RvzIFWDql3aEX_nae46RVD9uBY5xnx_J79vs5fu9nhD442PU4I8vEeU4SxlOXGG1sAvs2rQDvctuSJF1MxWTGvl3z6x102ufChLDKbu2Pa3q7Wnclo240R3dVNfqZBfZ0kYWTojQE64QMdiaDlZ_83YR5KNYzEtAkSHeJMzHGC8YrUHYTehKY1CjZck4th_-Wj3oIg7a-6Pw5etaBSJzHfu6hHV-_QEeXkYV6dYyvNklVi2N8hC83_NSrfTSbXHzJCW7iLfSgF2xW-Lb6Mc0XuKqxDXbQfMJ5G-kBnq0rweHalVvd_F5gXTscE7dW0EwbZOtfotn52dXpJOluV0gsE2KZsMynXmfUpSWRXKbOeEBDNjVjeE8MMc4qxVJvhYddjx1z5pQR0kruuKZe0Fdot57X_g3CxqTCm1J6rRXj0o2JoYyUGhwwuEg7HqCsH9bCdtTj4QaMP0UfY_arCKoogiqKqIoB-riucxeJNx6V_hy0tZYMpNltwby5KTqrKQBMEk5LI71QTOtMlVDTAsJVpbCGqQHiva6LLRuEpqpHP37YG0YBkzOcuOjaz-9BSAL6hDWSiAF6HS1m3UUqFAX8St7-51cP0NPwFKOI3qHdZXPv3wNAWpphOwOG6En-9ftkOmx_M_wDg8QPbA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcAF8WZ5Ggl6oekmju2skTgsj7Kl3VUFu1Jvxq-gAM1W2a1QLvwp_iDjxNnVHugBqVfbcSLPeOaz8vkbhF5YOPVYneWRdYxElMU20kqbCM5tSgDeZaYRSRpP-GhGP52wky30p7sL42mVIfa3Mb2J1qGlH1azf1YU_S-JV0_nif9TFHuyTmBWHrr6F5zbFm8O3oORXxKy_2H6bhSF0gKRoZwvI5q42KkktXFOMpbFVjuAAibWA-gnmmhrhKCxM9wB5DcDRq3QPDMZs0yljqcw7xV0lUK48GUT9n6veSWCdhIIaeQ_L9zUaUllYCCvEU7SPS_dlpKNbNgUDdhIiv8CvU3y27-JbgTUioftwtxCW668jXaOW9nrehdP17e4Frt4Bx-vBbHrO2g2Gn8cEly1Ze_BEbCu8WnxeTJc4KLExjte9RoPG2oJpNLQgn2dl1NV_VhgVVrc3hSrYZqG1evuotmlrPk9tF3OS_cAYa1j7nSeOaUEZZkdEJ1SkivI-JCTzaCHkm5ZpQla577kxk_Zkdq-S28K6U0hW1P00KvVM2et0seFo996a61GepXupmFefZPBTSWgV8LSXGeOC6pUInJ40gCkFjk3mooeYp2t5YbTw1TFhS9_3jmGhGjgf_Go0s3PYVAGcBeCMuE9dL_1mNUnplykAJjJw_986zN0bTQdH8mjg8nhI3Td97QUpsdoe1mduyeAzpb6abMbMPp62dvvL1o8Sj0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HMGA2+regulation+by+miRNAs+in+cancer%3A+Affecting+cancer+hallmarks+and+therapy+response&rft.jtitle=Pharmacological+research&rft.au=Hashemi%2C+Mehrdad&rft.au=Rashidi%2C+Mohsen&rft.au=Hushmandi%2C+Kiavash&rft.au=ten+Hagen%2C+Timo+L.M.&rft.date=2023-04-01&rft.pub=Elsevier+Ltd&rft.issn=1043-6618&rft.eissn=1096-1186&rft.volume=190&rft_id=info:doi/10.1016%2Fj.phrs.2023.106732&rft.externalDocID=S1043661823000889
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-6618&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-6618&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-6618&client=summon